Curriculum Vitae

PERSONAL DETAILS
BIOGRAPHY

Professor Dr Hasniza Zaman Huri obtained her PhD and Master in Clinical Pharmacy from the National University of Malaysia and B. Pharm (Honours) from the Universiti Malaya. She is the founder Dean of Faculty of Pharmacy, a newly established and the 13th faculty in the University of Malaya since 1 September 2019, and a Professor of Clinical Pharmacy and Pharmacogenomics in the Department of Clinical Pharmacy and Pharmacy Practice. Professor Dr Hasniza and Type 2 Diabetes is inseparable. Her research covers optimal management, biomarkers, insulin-resistant study, and all areas of Type 2 Diabetes, and clinical pharmacy encompasses associations of drug response and related factors, drug-related problems and pharmaceutical care issues, general biomarkers study, pharmacogenomics-pharmacodynamics study, gene-disease-drug response associations and PK-PD study. She has published more than 80 papers indexed in WOS in her area of expertise. She held various critical administrative posts, among others the Manager of Clinical Investigation Centre (CIC) from 2012-2015 and later appointed as the Director/Head of CIC (2015-2019). CIC, University Malaya Medical Centre is a world-class, reputable and multi-winning clinical trial centre. Under her tenure, CIC has won many accolades at the international levels, procured around 590 clinical trials, and worked with 300 pharmaceutical sponsors and CROs worldwide. CIC recognized as the first Prime Site for Quintiles (now is IQVIA) in Asia, the first Strategic Alliance Site for Parexel Inc in Malaysia and the first Pfizer’s INSPIRE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) Site in Malaysia and many more. Previously, Professor Dr Hasniza was also leading the research thrust of UMMC strategic planning. At present, she is also the Honorary Visiting Consultant at CIC and a permanent member of the Drug Control Authority (DCA) Ministry of Health, Malaysia.

ADMINISTRATIVE DUTIES
(Role),(Level),(Duration)
  • Dean, UNIVERSITI MALAYA, 01/01/2022 to present
  • Investigation Team Pool, University Malaya, 02/01/2020 to 02/01/2022
  • Dean, UNIVERSITI MALAYA, 01/09/2021 to 31/12/2021
  • Dean, UNIVERSITI MALAYA, 01/09/2019 to 31/08/2021
  • Dean, Faculty of Pharmacy, University Malaya, 01/09/2019 to 31/08/2021
  • Head of Department, University Malaya, 01/08/2019 to 11/08/2020
  • Committee Member for Jawatankuasa Pengurusan Strategik UMMC, University Malaya, 16/10/2017 to 31/12/2020
  • Secretary of Risk Management Committee of Research (UMMC), University Malaya, 16/10/2017 to 31/12/2020
  • Head of Thrust 2 (Research) for UMMC Strategic Planning Program, University Malaya, 16/10/2017 to 31/12/2020
  • Deputy Chairman of Human Research Protection Program (HRPP), University Malaya, 25/08/2017 to 31/12/2020
  • Head, UNIVERSITI MALAYA, 01/01/2018 to 31/12/2019
  • Head of Department, International, 15/08/2015 to 30/09/2019
  • Committee Member - Faculty of Medicine Central Research Facilities (JFGPP), University Malaya, 01/03/2017 to 31/07/2018
  • Chairman, University Malaya, 01/02/2017 to 31/07/2018
  • Head of Department -Department of Clinical Research (CIC), University Malaya, 01/08/2016 to 31/07/2018
  • Head, UNIVERSITI MALAYA, 01/01/2016 to 31/12/2017
  • Member of Price Negotiation Committee - Renovation of Clinical Investigation Centre, University Malaya, 20/04/2016 to 20/04/2016
  • Director and Head - Clinical Investigation Centre (CIC), University Malaya Medical Centre, University Malaya, 15/08/2015 to present
  • Head of Unit - Clinical and Practice Pharmacy, Faculty, 10/07/2015 to present
  • Manager, International, 01/10/2013 to 14/08/2015
  • Manager of Clinical Investigation Centre (CIC), Faculty of Medicine, University of Malaya, International, 01/10/2012 to 14/08/2015
  • Faculty Appeal Committee Member for Semester Program, Faculty, 18/11/2014 to present
  • Chairman of Tender Committee - Proposal for Renovation and Upgrading including Civil, Mechanical, Electrical and ICT Works for Clinical Investigation Centre (CIC) Premise at 2nd Floor, Nursing Educational Science Complex, University Malaya Medical Centre, University Malaya, 25/04/2014 to 31/12/2014
  • Chairman of Technical Assessment Committee Members for Purchasing of Real Time PCR, University Malaya, 16/10/2013 to present
  • Postgraduate (High Degree) Committee, Department of Pharmacy, Faculty of Medicine, University of Malaya., University Malaya, 02/01/2013 to present
  • Founder President of Pharmacy Alumni Society,University of Malaya (PhAUM), University Malaya, 09/08/2012 to 09/02/2013
  • Secretary of CIC Advisory Board Committee, University Malaya, 01/10/2012 to present
  • Level Coordinator (Professional year), Faculty, 03/09/2012 to present
  • Coordinator of Hospital Pharmacy Services module, Faculty, 23/07/2011 to 01/09/2012
  • Academic advisor, Faculty, 12/09/2011 to present
  • Coordinator of Students Achievement Award, Faculty, 05/08/2011 to present
  • Coordinator of Integrated Pharmacotherapy module, Faculty, 22/07/2011 to present
  • Coordinator of Health Supplements module, Faculty, 22/07/2011 to present
  • Coordinator of Introduction to Clinical Pharmacy module , Faculty, 22/07/2011 to present
  • Advisor of Pharmacy Society, University of Malaya, University Malaya, 08/02/2005 to 19/01/2008
  • Re-accreditation of UM Pharmacy Course (The accompanying lecturer for the visit by the Malaysian Pharmacy Board), Faculty, 16/07/2007 to 18/07/2007
  • Quality Manager, Faculty, 08/02/2005 to 08/01/2007
  • Academic Advisor, Faculty, 08/02/2005 to 26/12/2007
  • Coordinator of Health Supplements module, Faculty, 05/02/2005 to 26/03/2007
  • Coordinator of Endocrine, Gastrointestinal System & Therapy module, Faculty, 05/02/2005 to 26/03/2007
  • Coordinator of Clinical Pharmacy & Therapeutics I module, 05/02/2005 to 26/12/2007
  • Coordinator of Respiratory, Blood System & Therapy module, Faculty, 05/02/2005 to 30/06/2006
ACADEMIC QUALIFICATION
(Qualification),(Field),(Institution),(Year)
  • PhD(UM), PHILOSOPHY, UNIVERSITI KEBANGSAAN MALAYSIA (UKM)
  • MPharm(Clinical)(UKM), FARMASI KLINIKAL, UNIVERSITI KEBANGSAAN MALAYSIA (UKM)
  • BPHARM (Hons)(UM), FARMASI, UNIVERSITI MALAYA (UM)
MEMBERSHIPS
(Organisation),(Role),(Duration),(Level)
  • SAS Eminent Fellow Membership, Fellow, Since 2021 (International)
  • Committee Member of UM ICT , Member, 2021 to 2022 (University)
  • Expert Member for Development of Pharmacy Expertise via Subject Matter Expert, Advisory Board, 2021 to 2022 (National)
  • Board Members of Akademi Pengajian Melayu, Universiti Malaya, Advisory Board, 2020 to 2022 (University)
  • Editorial Board - Malaysian Journal of Pharmaceutical Sciences, Advisory Board, 2020 to 2022 (National)
  • Member of Drug Control Authority (DCA), Advisory Board, 2020 to 2022 (National)
  • Member of Asian Council of Science Editors, Member, 2021 to 2021 (International)
  • Pharmacy Dean Council Member, Committee Member, 2020 to 2021 (National)
  • Committee Member for Evaluation of Research Funding , Committee Member, 2020 to 2021 (National)
SPECIALIZATION
(Area)
Area of Expertise
  • (Type 2 Diabetes Mellitus)
  • Clinical Trials (Clinical trials)
  • CLINICAL PHARMACY (Cardiovascular; Coronary Artery Disease)
  • UROLOGY (Erectile Dysfunction; Benign Prostatic Hyperplasia)
  • Renal- Chronic Kidney Disease (Biomarkers and Genetic markers)
  • Biomarkers Study
  • Insulin Resistant Study
  • (Disease-Gene Interactions, Disease-Drug Modelling)
  • PHARMACO-GENOMIC (Pharmacogenomics-Pharmacodynamics, Gene Polymorphisms, Drug-Gene interactions, Drug-Disease , Gene Expressions)
  • CLINICAL PHARMACY (Endocrinology [Type 2 Diabetes Mellitus]; Urology)
  • TEACHING
    (Course Title),(Level of Study),(Institution),(Academic Session)
    Teaching
  • MWEF4103 - CLINICAL PHARMACY AND PHARMACOTHERAPY II, First Degree, UNIVERSITY MALAYA (2018/2019 - 1 )
  • MIB4010 - PHARMACOTHERAPY FOR SPECIAL POPULATIONS, First Degree, UNIVERSITY MALAYA (2018/2019 - 1 )
  • MIB3021 - PHARMACEUTICAL BIOTECHNOLOGY, First Degree, UNIVERSITY MALAYA (2018/2019 - 2 )
  • MVX8001 - RESEARCH METHODOLOGY, Post Graduate, UNIVERSITY MALAYA (2019/2020 - 1 )
  • OIA4008 - CLINICAL CLERKSHIP II, First Degree, UNIVERSITY MALAYA (2019/2020 - 2 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2019/2020 - 1 )
  • OIA3005 - PHARMACOTHERAPY FOR ENDOCRINE DISORDERS, First Degree, UNIVERSITY MALAYA (2019/2020 - 1 )
  • OIA4005 - CLINICAL CLERKSHIP, First Degree, UNIVERSITY MALAYA (2019/2020 - 1 )
  • OMX7001 - Research Methodology, Post Graduate, UNIVERSITY MALAYA (2020/2021 - 2 )
  • OVA8001 - Research Methodology, Post Graduate, UNIVERSITY MALAYA (2020/2021 - 2 )
  • MIB4008 - CLINICAL CLERKSHIP II, First Degree, UNIVERSITY MALAYA (2018/2019 - 2 )
  • MWEF4111 - CLINICAL CLERKSHIP II, First Degree, UNIVERSITY MALAYA (2016/2017 - 2 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2018/2019 - 1 )
  • MVX8001 - RESEARCH METHODOLOGY, Post Graduate, UNIVERSITY MALAYA (2018/2019 - 2 )
  • MWEF3102 - INTRODUCTION TO CLINICAL PHARMACY, First Degree, UNIVERSITY MALAYA (2016/2017 - 1 )
  • MVX8001 - RESEARCH METHODOLOGY, Post Graduate, UNIVERSITY MALAYA (2017/2018 - 1 )
  • MIB4005 - CLINICAL CLERKSHIP I, First Degree, UNIVERSITY MALAYA (2018/2019 - 1 )
  • MIB3005 - PHARMACOTHERAPY FOR ENDOCRINE DISORDERS, First Degree, UNIVERSITY MALAYA (2017/2018 - 1 )
  • MWEF4103 - CLINICAL PHARMACY AND PHARMACOTHERAPY II, First Degree, UNIVERSITY MALAYA (2017/2018 - 1 )
  • MWEF4105 - CLINICAL CLERKSHIP I, First Degree, UNIVERSITY MALAYA (2017/2018 - 1 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2017/2018 - 1 )
  • MBEB4104 - QUALITY CONTROL AND LABORATORY MANAGEMENT, First Degree, UNIVERSITY MALAYA (2017/2018 - 2 )
  • MWEF3108 - PHARMACEUTICAL BIOTECHNOLOGY, First Degree, UNIVERSITY MALAYA (2017/2018 - 2 )
  • MWEF4108 - INTERGRATED PHARMACOTHERAPY, First Degree, UNIVERSITY MALAYA (2017/2018 - 2 )
  • MWEF4111 - CLINICAL CLERKSHIP II, First Degree, UNIVERSITY MALAYA (2017/2018 - 2 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2017/2018 - 2 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate (2018/2019 - 2 )
  • MIC4006 - LABORATORY MANAGEMENT AND QUALITY CONTROL, First Degree, UNIVERSITY MALAYA (2018/2019 - 2 )
  • MWEF3102 - INTRODUCTION TO CLINICAL PHARMACY, First Degree, UNIVERSITY MALAYA (2015/2016 - 1 )
  • MIB3005 - PHARMACOTHERAPY FOR ENDOCRINE DISORDERS, First Degree, UNIVERSITY MALAYA (2018/2019 - 1 )
  • MVX8001 - RESEARCH METHODOLOGY, Post Graduate, UNIVERSITY MALAYA (2018/2019 - 1 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2016/2017 - 2 )
  • MWEF3168 - CLINICAL PHARMACY AND THERAPEUTICS II, First Degree, UNIVERSITY MALAYA (2006/2007 - 2)
  • MWEF4105 - CLINICAL CLERKSHIP I, First Degree, UNIVERSITY MALAYA (2016/2017 - 1 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2016/2017 - 1 )
  • MWEF3108 - PHARMACEUTICAL BIOTECHNOLOGY, First Degree, UNIVERSITY MALAYA (2016/2017 - 2 )
  • MBEB4104 - QUALITY CONTROL AND LABORATORY MANAGEMENT, First Degree, UNIVERSITY MALAYA (2016/2017 - 2 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2015/2016 - 2 )
  • MWEF3102 - INTRODUCTION TO CLINICAL PHARMACY, First Degree, UNIVERSITY MALAYA (2012/2013 - )
  • MWEF4111 - CLINICAL CLERKSHIP II, First Degree, UNIVERSITY MALAYA (2013/2014 - 2 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2014/2015 - 1 )
  • MWEF3108 - PHARMACEUTICAL BIOTECHNOLOGY, First Degree, UNIVERSITY MALAYA (2014/2015 - 2 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2014/2015 - 2 )
  • MWEF4105 - CLINICAL CLERKSHIP I, First Degree, UNIVERSITY MALAYA (2014/2015 - )
  • MWEF1132 - ENDOCRINE, GASTROINTESTINAL SYSTEM & THERAPY, First Degree, UNIVERSITY MALAYA (2005/2006 - 1)
  • MWEF2163 - CLINICAL PHARMACY & THERAPEUTICS I, First Degree, UNIVERSITY MALAYA (2004/2005 - 1)
  • MWEF3161 - CLINICAL PHARMACY AND THERAPEUTICS IV, First Degree, UNIVERSITY MALAYA (2005/2006 - 2)
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2015/2016 - 1 )
  • MWEF3169 - CLINICAL PHARMACY & THERAPEUTICS III, First Degree, UNIVERSITY MALAYA (2006/2007 - 1)
  • MWEF3102 - INTRODUCTION TO CLINICAL PHARMACY, First Degree, UNIVERSITY MALAYA (2013/2014 - 1 )
  • OIA4005 - CLINICAL CLERKSHIP, First Degree, UNIVERSITY MALAYA (2020/2021 - 1 )
  • MXGZ6101 - RESEARCH METHODOLOGY FOR RESEARCH MODE PROGRAMMES, Post Graduate, UNIVERSITY MALAYA (2013/2014 - 2 )
  • MWEF3107 - CLINICAL PHARMACY AND PHARMACOTHERAPY I, First Degree, UNIVERSITY MALAYA (2012/2013 - )
  • MWEF4105 - CLINICAL CLERKSHIP I, First Degree, UNIVERSITY MALAYA (2013/2014 - 1 )
  • MWEF4103 - CLINICAL PHARMACY AND PHARMACOTHERAPY II, First Degree, UNIVERSITY MALAYA (2013/2014 - 1 )
  • MWEF3108 - PHARMACEUTICAL BIOTECHNOLOGY, First Degree, UNIVERSITY MALAYA (2013/2014 - 2 )
  • MBEB4104 - QUALITY CONTROL AND LABORATORY MANAGEMENT, First Degree, UNIVERSITY MALAYA (2013/2014 - 2 )
  • MWEF2348 - NUTRITIONAL SUPPLEMENTS, First Degree, UNIVERSITY MALAYA (2006/2007 - 2)
  • MWEF4103 - CLINICAL PHARMACY AND PHARMACOTHERAPY II, First Degree, UNIVERSITY MALAYA (2012/2013 - 3 )
  • MWEF4108 - INTERGRATED PHARMACOTHERAPY, First Degree, UNIVERSITY MALAYA (2012/2013 - )
  • MWEF4105 - CLINICAL CLERKSHIP I, First Degree, UNIVERSITY MALAYA (2012/2013 - )
  • MWEF4103 - CLINICAL PHARMACY AND PHARMACOTHERAPY II, First Degree, UNIVERSITY MALAYA (2012/2013 - 1 )
  • MWEF4104 - HOSPITAL PHARMACY SERVICES, First Degree, UNIVERSITY MALAYA (2011/2012 - 1 )
  • MWEF3108 - PHARMACEUTICAL BIOTECHNOLOGY, First Degree, UNIVERSITY MALAYA (2012/2013 - 2 )
  • MWEF2163 - CLINICAL PHARMACY & THERAPEUTICS I, First Degree, UNIVERSITY MALAYA (2006/2007 - 1)
  • MWEF3161 - CLINICAL PHARMACY AND THERAPEUTICS IV, First Degree, UNIVERSITY MALAYA (2006/2007 - 2)
  • MWEF2163 - CLINICAL PHARMACY & THERAPEUTICS I, First Degree, UNIVERSITY MALAYA (2007/2008 - 1)
  • MWEF1132 - ENDOCRINE, GASTROINTESTINAL SYSTEM & THERAPY, First Degree, UNIVERSITY MALAYA (2006/2007 - 1)
  • MWEF1132 - ENDOCRINE, GASTROINTESTINAL SYSTEM & THERAPY, First Degree, UNIVERSITY MALAYA (2007/2008 - 1)
  • MWEF3169 - CLINICAL PHARMACY & THERAPEUTICS III, First Degree, UNIVERSITY MALAYA (2007/2008 - 1)
  • MWEF4105 - CLINICAL CLERKSHIP I, First Degree, UNIVERSITY MALAYA (2015/2016 - 1 )
  • MWEF4105 - CLINICAL CLERKSHIP I, First Degree, UNIVERSITY MALAYA (2010/2011 - 1 )
  • MWEF4111 - CLINICAL CLERKSHIP II, First Degree, UNIVERSITY MALAYA (2011/2012 - )
  • MWEF4103 - CLINICAL PHARMACY AND PHARMACOTHERAPY II, First Degree, UNIVERSITY MALAYA (2011/2012 - 1 )
  • MWEF3108 - PHARMACEUTICAL BIOTECHNOLOGY, First Degree, UNIVERSITY MALAYA (2011/2012 - 2 )
  • MWEF4108 - INTERGRATED PHARMACOTHERAPY, First Degree, UNIVERSITY MALAYA (2011/2012 - 2 )
  • MWEF4111 - CLINICAL CLERKSHIP II, First Degree, UNIVERSITY MALAYA (2011/2012 - 2 )
  • MWEF3102 - INTRODUCTION TO CLINICAL PHARMACY, First Degree, UNIVERSITY MALAYA (2011/2012 - )
  • MWEF4111 - CLINICAL CLERKSHIP II, First Degree, UNIVERSITY MALAYA (2012/2013 - 2 )
  • MWEF3108 - PHARMACEUTICAL BIOTECHNOLOGY, First Degree, UNIVERSITY MALAYA (2015/2016 - 2 )
  • MWEF4111 - CLINICAL CLERKSHIP II, First Degree, UNIVERSITY MALAYA (2015/2016 - 2 )
  • MWEF2163 - CLINICAL PHARMACY & THERAPEUTICS I, First Degree, UNIVERSITY MALAYA (2005/2006 - 1)
  • MBEB4104 - QUALITY CONTROL AND LABORATORY MANAGEMENT, First Degree, UNIVERSITY MALAYA (2014/2015 - 2 )
  • MWEF3169 - CLINICAL PHARMACY & THERAPEUTICS III, First Degree, UNIVERSITY MALAYA (2005/2006 - 1)
  • MWEF3168 - CLINICAL PHARMACY AND THERAPEUTICS II, First Degree, UNIVERSITY MALAYA (2005/2006 - 2)
  • MWEF3102 - INTRODUCTION TO CLINICAL PHARMACY, First Degree, UNIVERSITY MALAYA (2014/2015 - 1 )
  • MWEF2348 - NUTRITIONAL SUPPLEMENTS, First Degree, UNIVERSITY MALAYA (2005/2006 - 2)
  • MWEF2138 - RESPIRATORY BLOOD SYSTEM & THERAPY, First Degree, UNIVERSITY MALAYA (2004/2005 - 2)
  • MWEF4111 - CLINICAL CLERKSHIP II, First Degree, UNIVERSITY MALAYA (2014/2015 - 2 )
  • MWEF3169 - CLINICAL PHARMACY & THERAPEUTICS III, First Degree, UNIVERSITY MALAYA (2004/2005 - 1)
  • OIA3005 - PHARMACOTHERAPY FOR ENDOCRINE DISORDERS, First Degree, UNIVERSITY MALAYA (2020/2021 - 2 )
  • MWEF3168 - CLINICAL PHARMACY AND THERAPEUTICS II, First Degree, UNIVERSITY MALAYA (2004/2005 - 2)
  • MWEF3161 - CLINICAL PHARMACY AND THERAPEUTICS IV, First Degree, UNIVERSITY MALAYA (2004/2005 - 2)
  • MWEF2146 - PHARMACY PRACTICE II, First Degree, UNIVERSITY MALAYA (2004/2005 - 1)
  • Teaching Activity
  • OIA3005 - PHARMACOTHERAPY FOR ENDOCRINE DISORDERS, Bachelor/First Degree, University Malaya (2021)
  • OMX7001 - RESEARCH METHODOLOGY, Master, University Malaya (2021)
  • PUBLICATIONS
    (Title of publication in APA style)
    WoS
    2022
    • Abousheishaa, Aya Ahmed; Sulaiman, Ahmad Hatim; Huri, Hasniza Zaman; Kamis, Siti Fatimah Binti; Hamidi, Hafizah; Ang, Wei Chern; bin Zainal, Zainol Akbar; Shamsuddin, Noorasyikin; Guan, Ng Chong (2022). Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study, BMC HEALTH SERVICES RESEARCH. 22(1), . doi:10.1186/s12913-022-07681-4
    2021
    • Mokhtar, Fadzlin Mohd; Sathar, Jameela; Huri, Hasniza Zaman (2021). Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention, HEALTHCARE. 9(12), . doi:10.3390/healthcare9121702
    • Loganadan, N. K., Huri, H. Z., Vethakkan, S. R., & Hussein, Z. (2021). Pharmacogenetics of sulfonylurea-induced hypoglycemia in Type 2 diabetes patients: the SUCLINGEN study. Pharmacogenomics, 22(16), 1057-1068. doi: 10.2217/pgs-2021-0059
    • Elnaem, M. H., Kamarudin, N. H., Syed, N. K., Huri, H. Z., Dehele, I. S., & Cheema, E. (2021). Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia. International journal of environmental research and public health, 18(17), 14. doi: 10.3390/ijerph18179306
    • Perumalsamy, S., Ahmad, W. A. W., & Huri, H. Z. (2021). Retinol-Binding Protein-4-A Predictor of Insulin Resistance and the Severity of Coronary Artery Disease in Type 2 Diabetes Patients with Coronary Artery Disease. Biology-Basel, 10(9), 16. doi: 10.3390/biology10090858
    • Perumalsamy, S., Ahmad, W. A. W., & Huri, H. Z. (2021). Single Nucleotide Polymorphism rs17173608 in the Chemerin Encoding Gene: Is It a Predictor of Insulin Resistance and Severity of Coronary Artery Disease in Non-Obese Type 2 Diabetes? Healthcare, 9(6), 15. doi: 10.3390/healthcare9060623
    • Perumalsamy, S; Huri, HZ; Ahmad, WAW (2021). Association of YKL-40 Encoding Gene CHI3L1 rs946263 with Insulin Resistance and Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus Patients, METABOLISM-CLINICAL AND EXPERIMENTAL. 116(), 22-22. doi:10.1016/j.metabol.2020.154520
    • Boon, TK; Huri, HZ; Hashim, NM; Ibrahim, L; Saiman, MZ; Zakaria, ZH; Sakika, KA; Hisham, SF; Mansor, A (2021). Pharmacometabolomics of Meformin Demonstrated Insulin Sensitivity Related Pathways at Peak Plasma Concentration on Healthy Volunteers - Preliminary Results, METABOLISM-CLINICAL AND EXPERIMENTAL. 116(), 28-28. doi:10.1016/j.metabol.2020.154536
    • Zaini, S., Sulaiman, A. H., Huri, H. Z., Koh, O. H., Gill, J. S., Francis, B., . . . Guan, N. C. (2021). Patient-Centred Communication in the Use of Antidepressants among People with Depression: A Scoping Review. Sains Malaysiana, 50(1), 161-170. doi: 10.17576/jsm-2021-5001-16
    2020
    • Yugavathy, N., Huri, H. Z., Kun, L. S., Gafor, A. H. B., Geot, W. M., Bavanandan, S., & Seng, W. H. (2020). Clinical and genetic markers of erythropoietin deficiency anemia in chronic kidney disease (predialysis) patients. Biomarkers in Medicine, 14(12), 1099-1108. doi: 10.2217/bmm-2020-0205
    • Loganadan, N. K., Huri, H. Z., Vethakkan, S. R., & Hussein, Z. (2020). Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study. Pharmacogenomics, 21(9), 587-600. doi: 10.2217/pgs-2019-0171
    • Abousheishaa, A. A., Sulaiman, A. H., Huri, H. Z., Zaini, S., Othman, N. A., bin Aladdin, Z., & Guan, N. C. (2020). Global Scope of Hospital Pharmacy Practice: A Scoping Review. Healthcare, 8(2), 14. doi: 10.3390/healthcare8020143
    • Lin, S. N., Phang, K. K., Toh, S. H., Chee, K. H., & Huri, H. Z. (2020). Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction. Frontiers in Endocrinology, 11, 10. doi: 10.3389/fendo.2020.00448
    2019
    • Elnaem, M. H., Mohamed, M. H. N., Huri, H. Z., Shah, A. S. M. (2019). Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings. Therapeutics and Clinical Risk Management, 15, 137-145. doi:10.2147/tcrm.s182716
    • Elnaem, M. H., Mohamed, M. H. N., Huri, H. Z. (2019). Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design. Plos One, 14(9), 13. doi: 10.1371/journal.pone.0220458
    • Ma, S. N., Huri, H. Z., Yahya, F. (2019). Drug-related problems in patients with rheumatoid arthritis. Therapeutics and Clinical Risk Management, 15, 505-524. doi:10.2147/tcrm.s194921
    2018
    • Abu Bakar, M. H., Hairunisa, N., Huri, H. Z. (2018). Reduced mitochondrial DNA content in lymphocytes is associated with insulin resistance and inflammation in patients with impaired fasting glucose. Clinical and Experimental Medicine, 18(3), 373-382. doi:10.1007/s10238-018-0495-4
    2015
    • Abu Bakar, M. H., Sarmidi, M. R., Cheng, K. K., Khan, A. A., Suan, C. L., Huri, H. Z., Yaakob, H. (2015). Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes. Molecular Biosystems, 11(7), 1742-1774.
    2014
    • Huri, H. Z., Permalu, V., Vethakkan, S. R. (2014). Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study, Plos One. 9(9), 9
    • Huri, H. Z., Choo, T. L., Sulaiman, C. Z., Mark, R., Razack, A. H. A. (2014). Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study, Bmj Open. 4(7), 9
    • Sarker, M. M. R., Islam, K. N., Huri, H. Z., Rahman, M., Imam, H., Hosen, M. B., Mohammad, N., Sarker, M. Z. I. (2014). Studies of the Impact of Occupational Exposure of Pharmaceutical Workers on the Development of Antimicrobial Drug Resistance, Journal of Occupational Health. 56(4), 260-270
    • Huri, H. Z., Xiang, L. T. (2014). Factors Associated with Treatment Response to Antidiabetic Agents in Compliant Type 2 Diabetes Mellitus Patients: A Brief Summary of 5-Year Data, Tropical Journal of Pharmaceutical Research. 13(3), 429-4351596-5996.
    • Huri, H. Z., Xin, C. H., Sulaiman, C. Z. (2014). Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study, Plos One. 9(1), 14
    • Jamaluddin, J. L., Huri, H. Z., Vethakkan, S. R., Mustafa, N. (2014). Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes, Pharmacogenomics. 15(2), 235-249
    • Abu Bakar, M. H., Sarmidi, M. R., Kai, C. K., Huri, H. Z., Yaakob, H. (2014). Amelioration of Mitochondrial Dysfunction-Induced Insulin Resistance in Differentiated 3T3-L1 Adipocytes via Inhibition of NF-kappa B Pathways, International Journal of Molecular Sciences. 15(12), 22227-22257
    2013
    • Huri, H. Z., Ling, L. C. (2013). Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia, Bmc Public Health. 13(), 13
    • Huri, H. Z., Wee, H. F. (2013). Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study, Bmc Endocrine Disorders. 13(), 12
    2010
    • Huri, H. Z., Wei, A. T. L., Pendek, R., Sulaiman, C. Z., Widodo, R. T. (2010). Factors Influencing Utilization of Different Types of Sulphonylureas Amongst Type 2 Diabetes Patients, Latin American Journal of Pharmacy. 29(6), 1044-1048
    2009
    • Huri, H. Z., Foong, G. T. K., Pendek, R., Widodo, R. T. (2009). Different characteristics of diabetic ketoacidosis between type 1 and type 2 diabetes patients in Malaysia, Asian Biomedicine. 3(2), 201-205
    ESCI
    2021
    • Abousheishaa, A. A., Sue-Yin, L., Khin, K. C., Sulaiman, A. H., Huri, H. Z., & Guan, N. C. (2021). A Clinical Practice Guideline Summary for Pharmacological Management of Adults with Major Depressive Disorder in Malaysia. Journal of Pharmaceutical Research International, 33(45B), 405-411. doi: 10.9734/JPRI/2021/v33i45B32821
    Refereed Journals
    2020
    • Navin Kumar Loganadan, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Zanariah Hussein. Clinical and genetic predictors of secondary sulfonylurea failure in type 2 diabetes patients: The SUCLINGEN study, Pharmacogenomics 2020, 10.2217/pgs-2019-0171 (published online May 29 2020) (WoS)
    • Aya Ahmed Abousheishaa *, Ahmad Hatim Sulaiman, Hasniza Zaman Huri, Syahrir Zaini, Nurul Adha Othman, Zulhilmi bin Aladdin, Ng Chong Guan. GLOBAL SCOPE OF HOSPITAL PHARMACY PRACTICE: A SCOPING REVIEW; Healthcare 2020, 8, 143; doi:10.3390/healthcare8020143 (WoS)
    • Nava Yugavathy, Hasniza Zaman Huri, Lim Soo Kun, Abdul Halim Bin Abdul Gafor, Wong Muh Geot, Sunita Bavanandan, Wong Hing Seng. Clinical and Genetic Marker of Erythropoietin Deficiency Anaemia in Chronic Kidney Disease (pre-dialysis) Patients. Biomark. Med. (2020) 14(12), 1099 1108 (WoS)
    • Shu Ning Lin, Kok Kit Phang, Seng Hsiung Toh, Kok Han Chee, Hasniza Zaman Huri. Heart Failure with Type 2 Diabetes Mellitus: Association between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction, Frontiers in Endocrinology, (Clinical Diabetes) - Front. Endocrinol., 10 July 2020 | https://doi.org/10.3389/fendo.2020.00448 (ISI-Indexed) (WoS)
    2019
    • MH Elnaem, MH Nik Mohamed, HZ Huri, SM Azarisman. Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings. Therapeutic and Clinical Risk Management 2019:15 1-9. (WoS)
    • Ma Shu Ning, Hasniza Zaman Huri. Fariz Yahya. Drug Related Problems in Patients with Rheumatoid Arthritis. Therapeutics and Clinical Risk Management 2019:15 505 524 (WoS)
    • Mohamed Hassan Elnaem, Mohamad Haniki Nik Mohamed, Hasniza Zaman Huri. Pharmacist-led Academic Detailing Improves Statin Therapy Prescribing for Malaysian Patients with Type 2 Diabetes: Quasi-Experimental Design. 2019; PLoS ONE 14(9): e0220458. (WoS)
    • Mohamed Hassan Elnaem, Mohamad Haniki Nik Mohamed, Hasniza Zaman Huri. Pharmacist-led Academic Detailing Improves Statin Therapy Prescribing for Malaysian Patients with Type 2 Diabetes: Quasi-Experimental Design. Plos One 2019 (WoS)
    • Ma, SN; Huri, HZ; Yahya, F 2019. Drug-related problems in patients with rheumatoid arthritis. THERAPEUTICS AND CLINICAL RISK MANAGEMENT (WoS)
    2018
    • MH Elnaem, MH Nik Mohamed, HZ Huri, SM Azarisman. Patterns of statin therapy prescribing among hospitalized patients with Type 2 diabetes mellitus in two Malaysian tertiary hospitals. Tropical Journal of Pharmaceutical Research 2018 (accepted) (WoS)
    • Ying TJ, Zainal ZA, Wahab IA, Zamri F and Huri HZ. Attitude and Self-Medication practice on Antibiotic use amongst general public in Alor Setar, Kedah, Malaysia. Madridge J Pharm Res. 2018; 2(1): 40-46. (Non-WoS/Non-SCOPUS)
    • Ray Mond Mark, Hasniza Zaman Huri, Azad Hassan Abdul Razack. Demographic, Clinical and Lifestyle Predictors for Severity of Erectile Dysfunction and Biomarkers level in Malaysian Patients. Brazilian Journal of Pharmaceutical Sciences 2018 (accepted) (WoS)
    • MH Elnaem, MH Nik Mohamed, HZ Huri, SM Azarisman. Impact of Educational Outreach Intervention on Enhancing Healthcare Providers Knowledge about Statin Therapy Prescribing in Malaysian Patients with Type 2 Diabetes Mellitus. J Eval Clin Pract. 2018 Jun;24(3):521-527. doi: 10.1111/jep.12903. Epub 2018 Mar 6. (WoS)
    • Syahrir Zaini, NG Chong Guan , Ahmad Hatim Sulaiman, Nor Zuraida Zainal, Hasniza Zaman Huri, Siti Hadijah Shamsudin. The Use of Antidepressants for Physical and Psychological Symptoms in Cancer. Current Drug Target 2018 Feb 26. doi: 10.2174/1389450119666180226125026. [Epub ahead of print] (WoS)
    • Mohamad Hafizi Abu Bakar, Hasniza Zaman Huri, Nany Hairunisa. Reduced mitochondrial DNA content in lymphocytes is associated with insulin resistance and inflammation in patients with impaired fasting glucose. Clinical and Experimental Medicine 2018; 18(3): 373-382. (WoS)
    • Nor Razida Razali, Hasniza Zaman Huri, Luqman Ibrahim, Shireene Ratna Vethakkan, Bashar Mudhaffar Abdullah. Glycemic effects of simvastatin: Where do we stand? Braz. J. Pharm. Sci. 2018;54(1):e17192 (WoS)
    • Syahrir Zaini *, Harvin Anbu Manivanna Bharathy, Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Koh Ong Hui, Hasniza Zaman Huri, Siti Hadijah Shamsudin, Ng Chong Guan.Development of a strategic tool for shared decision-making in the use of antidepressants among patients with major depressive disorder: A focus group study IJERPH (2018) - accepted (WoS)
    • Hasniza Zaman Huri, Chua Chew Huey, Norasyikin Mustafa, Nor Fadhilah Mohamed, Tengku Ain Fathlun. Association of glycaemic control and progression of diabetic retinopathy in type 2 diabetes mellitus patients. Braz. J. Pharm. Sci. 2018;54(2):e17484 (WoS)
    2017
    • Maryam Abbaspour Babaei, Hasniza Zaman Huri, Behnam Kamalidehghan, Swee Keong Yeap, Fatemeh Ahmadipour. Apoptotic induction and inhibition of NF- B signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2 -oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis : an in vitro study. OncoTargets and Therapy 2017:10 277 294. (WoS)
    • Radwan H. Ahmed, Hasniza Zaman Huri, Sekaran Muniandy, Zaid Al-Hamodi, Boshra Al-absi, Abdulsamad Alsalahi, Muhammad Fazril Mohamad Razif. Altered Circulating Concentrations Of Active Glucagon-Like Peptide (GLP-1) And Dipeptidyl Peptidase 4 (DPP4) In Obese Subjects And Their Association With Insulin Resistance - Clinical Biochemistry (2017) - http://dx.doi.org/10.1016/j.clinbiochem.2017.03.008 (WoS)
    • Elnaem MH, Mohamed MH, Huri HZ, Azarisman SM, Elkalmi RM. Statin therapy prescribing for patients with type 2 diabetes mellitus: A review of current evidence and challenges. J Pharm Bioall Sci 2017;9:80-7. (WoS)
    • Syahrir Zaini, Ng Chong Guan, Ahmad Hatim Sulaiman, Hasniza Zaman Huri, Siti Hadijah Shamsudin. A Review of The Use of Mirtazapine in Cancer Patients. Malaysian Journal of Psychiatry 2017; 01-08-16 (WoS)
    • Mohamad Hafizi Abu Bakar, Hasniza Zaman Huri, Nany Hairunisa. Alterations of cultured myotubes and fasting plasma metabolite profiles related to mitochondrial dysfunction in Type 2 diabetes subjects. Free Radical Biology and Medicine, July 2017 Vol 108, Supplement 1, S24. (WoS)
    • Sangeetha Perumalsamy,1 Nurul Ain Aqilah Mohd Zin,1 Riyanto Teguh Widodo,1 Wan Azman Wan Ahmad,3 Shireene Ratna DB Vethakkan,4 Hasniza Zaman Huri*1,2. Chemokine like receptor- 1 (CMKLR-1) receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer. Curr Pharm Des. 2017 Jun 15. doi: 10.2174/1381612823666170616081256. (WoS)
    • Hasniza Zaman Huri, Ling Chui Fang, Azad Hassan Abdul Razack (2017). Drug-related problems in patients with erectile dysfunctions and multiple co-morbidities. Therapeutics and Clinical Risk Management,13, 407 419. (WoS)
    2016
    • Baig S, Seevasant I, Mohamad J, Mukheem A, Huri HZ, Kamarul T. Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand? Cell Death Dis. 2016 Jan 14;7:e2058 (WoS/SCOPUS)
    • Bashar Mudhaffar Abdullah, Saiful Irwan Zubairi, Hasniza Zaman Huri,Nany Hairunisa, Emad Yousif, Roma Choudhury Basu. Polyesters Based on Linoleic Acid for Biolubricant Basestocks: Low Temperature,Tribological and Rheological Properties. PLOS ONE | DOI:10.1371/journal.pone.0151603 March 23, 2016 (WoS)
    • Navin K. Loganadan. Hasniza Zaman Huri, Shireene R. Vethakkan, Zanariah Hussein. 2016. Association of rs5219 KCNJ11 Gene Polymorphism with Pancreatic Beta-Cell Function, Insulin Resistance, and Glycemic Control of Sulfonylurea-treated Malaysian Type 2 Diabetes Patients. Diabetes. 65 (1). A428 (WoS)
    • Radwan H. Ahmed, Hasniza Zaman Huri, Zaid Al-Hamodi, Sameer D. Salem, Boshra Al-absi, Sekaran Muniandy. Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian subjects. PLoS ONE 11(4): e0154369. doi:10.1371/journal.pone.0154369 (2016) (WoS)
    • Navin Kumar Loganadan, Hasniza Zaman Huri, Shireene Ratna Vethakkan and Zanariah Hussein. Genetic markers predicting sulphonylurea treatment outcomes in Type 2 Diabetes patients: current evidence and challenges for clinical implementation. The Pharmacogenomics Journal (Nature Publishing Group) (2016), 1-11. (WoS)
    • Maryam Abbaspour Babaei, Behnam Kamalidehghan, Mohammad Saleem, Hasniza Zaman Huri, Fatemeh Ahmadipour. Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells. Drug Design, Development and Therapy 2016:10 2443 2459. (WoS)
    • Maryam Abbaspour Babaei, Hasniza Zaman Huri, Behnam Kamalidehghan, Yeap Swee Keong, Fatemeh Ahmadipour. Apoptotic induction and inhibition of NF- B signaling pathway in human prostatic cancer PC3 cells by natural Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis: an in vitro study. OncoTargets and Therapy 2016 (accepted) (WoS)
    • Hasniza Zaman Huri, Nurul Diyana Mat Sanusi, Azad Hassan Abdul Razack, Raymond Mark. Association of psychological factors, patients knowledge, and management among patients with erectile dysfunction. Patient Preference and Adherence 2016:10 807 823 (WoS)
    • Nor Bahirah Kasim, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Luqman Ibrahim, Bashar Mudhaffar Abdullah. Genetic Polymorphisms Associated with Overweight and Obesity in Uncontrolled Type 2 Diabetes Mellitus. Biomarkers in Medicine - 10.2217/bmm-2015-0037 2016 Future Medicine Ltd (WoS)
    • Jazlina Liza Jamaluddin, Hasniza Zaman Huri. Shireene Ratna Vethakkan. Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in type 2 diabetes mellitus. Pharmacogenomics 2016 (accepted). (WoS)
    • Hasniza Zaman Huri, Muhammad Irfan Abdul Aziz, Shireene Ratna Vethakkan, Riyanto Teguh Widodo.Factors Associated with Hypoglycemia Episodes In Hospitalised Type 2 Diabetes Mellitus Patients. Trop J Pharm Res 2016; 15 (6): 1313-1320 (WoS)
    • Krisna Veni Balakrishnan, Bashar Mudhaffar Abdullah, Raghda Alsayed, Hasniza Zaman Huri, Nany Hairunisa, Ammal Esmaeel Ibrahim, and Emad Yousif. A Study on Cloning and Expression of HIV A Study on Cloning and Expression of HIVA Study on Cloning and Expression of HIV by Transient Transfection. Research Journal of Pharmaceutical, Biological and Chemical Sciences. November December 2016 RJPBCS 7(6) Page No. 1318-1330. (SCOPUS)
    2015
    • Yasmin Almualm, Hasniza Zaman Huri. Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review. Global Journal of Health Science; Vol. 7, No. 4; 2015 (SCOPUS)
    • Abu Bakar MH, Sarmidi MR, Yaakob H, Kai CK, HZ Huri. JNK Signaling Pathways Is Required For Mitochondrial Dysfunction-Induced Insulin Resistance In WRL-68 Human Liver Cell. Diabetes Technology & Therapeutics. Vol 17 (1): A154-155. (WoS/SCOPUS)
    • R.H. Ahmed, Z. Al-Hamodi, S.D. Salem, H.Z. Huri, S. Muniandy. Association of Genetic Polymorphisms of Dipeptidyl Peptidase-4 with Metabolic Syndrome Parameters in Malaysian Subjects. Public Health Genomics 2015;18(suppl 1):1 51 (DOI: 10.1159/000381430) (WoS/SCOPUS)
    • J.L. Jamaluddin, H.Z. Huri, S.R. Vethakkan, N. Mustafab,W.A.W. Ahmad. Pathway Mechanism of Potential Genomic Markers of Dipeptidyl Peptidase-4 Inhibitor Treatment Response in Type 2 Diabetes. Public Health Genomics 2015;18(suppl 1):1 51(DOI: 10.1159/000381430) (WoS/SCOPUS)
    • N.K. Loganadan, H.Z. Huri, S.R. Vethakkan, Z. Hussein. Impact of Single Nucleotide Polymorphisms(SNPs) of Type 2 Diabetes (T2D) Genes on Patients Response to Sulphonylurea Therapy.Public Health Genomics 2015;18 (suppl 1):1 51 (DOI: 10.1159/000381430) (WoS/SCOPUS)
    • Celastrol Protects Against Antimycin A-induced Insulin Resistance in Human Skeletal Muscle Cells. Mohamad Hafizi Abu Bakar, Kian-Kai Cheng, Mohamad Roji Sarmidi,Harisun Yaakob, Hasniza Zaman Huri. Molecules 2015; accepted (WoS/SCOPUS)
    • Mohamad Hafizi Abu Bakar, Mohamad Roji Sarmidi, Kian Kai Cheng, Abid Ali Khan, Lee Suan Chua, Hasniza Zaman Huri, Harisun Yaakob. Metabolomics The Complementary Field in Systems Biology: A Review on Obesity and Type 2 Diabetes. Molecular BioSystems 04/2015; DOI: 10.1039/C5MB00158G (WoS/SCOPUS)
    • Huri HZ, Lim LP, Lim SK. Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications. Drug Des Devel Ther. 2015 Aug 7;9:4355-71. (WoS)
    • Hasniza Zaman Huri, Lim Lay Peng, Lim Soo Kun. Glycaemic Control and Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients with Renal Complications. Drug Design, Development and Therapy 2015 (accepted) (WoS)
    • Hasniza Zaman Huri, Doris Ling Yew Hui, Wan Azman Wan Ahmad. Association between glycemic control and anti-diabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications. Drug Design, Development and Therapy (May 2015) - accepted (WoS)
    • Mohamad Hafizi Abu Bakar, Cheng Kian Kai,Wan Najihah Wan Hassan,Mohamad Roji Sarmidi, Harisun Yaakob, Hasniza Zaman Huri. Mitochondrial Dysfunction as a Central Event for Mechanisms Underlying Insulin Resistance: The Roles of Long Chain Fatty Acids, Diabetes/Metabolism Research and Reviews (in press) (WoS/SCOPUS)
    • Radwan H. Ahmed, Hasniza Zaman Huri, Zaid Al-Hamodi, Sameer. D. Salem and Sekaran Muniandy. The Serum Level of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects. PLos One (accepted October 2015) (WoS/SCOPUS)
    • Firas Hassan, Ayah Abdul Hameed, Ahemd Alshanon, Bashar Mudhaffar Abdullah,Hasniza Zaman Huri, Nany Hairunisa and Emad Yousif. Antitumor Activity for Gold (III) Complex by High Content Screening Technique (HCS) and Cell Viability Assay. Asian Journal of Biochemistry 10 (6): 252-266, 2015 (SCOPUS)
    • Krisna Veni Balakrishnan, Bashar Mudhaffar Abdullah, Hasniza Zaman Huri,Nany Hairunisa and Narazah Mohd Yusoff. A Review on Biologically Active N-Myristoylated HIV-1 Nef Protein. Asian Journal of Biochemistry 10 (6): 242-251, 2015 (SCOPUS)
    2014
    • Jazlina Liza Jamaluddin, Hasniza Zaman Huri, Shireene Ratna Vethakkan and Norlaila Mustafa. Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 Diabetes; Pharmacogenomics (Future Medicine) February 2014, Vol 15, No.2, 235-249. (WoS/SCOPUS)
    • Hasniza Zaman Huri, Chong Hui Xin, Che Zuraini Sulaiman. Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study. PLos ONE January 2014 Volume 9 :Issue 1, e86215. (WoS/SCOPUS)
    • Jamaluddin, J. L., Huri, H. Z., Vethakkan, S. R., Mustafa, N. 2014. Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes. Pharmacogenomics (WoS)
    • Md. Moklesur Rahman Sarker, Kamrun Nahar Islam, Hasniza Zaman Huri, Monzur Rahman, Hasan Imam, Md. Biplob Hosen, and Nur Mohammad. Studies of the impact of occupational exposure on pharmaceutical workers to the development of antimicrobial drug resistance. Journal of Occupational Health 2014; accepted. (WoS/SCOPUS)
    • Syed Ikmal SI, Zaman Huri H, Vethakkan SR, Wan Ahmad, WA. Potential biomarkers for insulin resistance and atherosclerosis among type 2 diabetes mellitus patients with coronary artery disease. Obesity Reviews 15 (Supp.2), 72, March 2014. (WoS/SCOPUS)
    • Hasniza Zaman Huri, Mohd Makmor-Bakry, Rosnani Hashim, Norlaila Mustafa, Wan Zurinah Wan Ngah. Effect of Interaction between Polymorphisms in the Insulin Receptor Substrate Genes in Type 2 Diabetes Mellitus Patients with Severe/Acute Hyperglycemia. Trop J Pharm Res 2014; 13(6): 889-894. (WoS/SCOPUS)
    • Hasniza Zaman Huri, Mohd Makmor-Bakry, Rosnani Hashim, Norlaila Mustafa, Wan Zurinah Wan Ngah. A Prospective Cohort Study of IRS Genes Polymorphisms in Type 2 Diabetes Mellitus Patients during Severe/Acute Hyperglycemia Phase: Part 2: Association with Glycemic Control. Trop J Pharm Res 2014; 13(6):903-906. (WoS/SCOPUS)
    • Hasniza Zaman Huri, Mohd Makmor-Bakry, Rosnani Hashim, Norlaila Mustafa, Wan Zurinah Wan Ngah. A Prospective Cohort Study of IRS Genes Polymorphisms in Type 2 Diabetes Mellitus Patients during Severe/Acute Hyperglycemia Phase: Part 1: Association with Insulin Resistance. Trop J Pharm Res 2014; 13(6): 895-901. (WoS/SCOPUS)
    • Huri, H. Z., Xin, C. H., Sulaiman, C. Z. 2014. Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study. Plos One (WoS)
    • Hasniza Zaman Huri, Tee Lian Choo, Che Zuraini Sulaiman, Raymond Mark, Azad Hassan Abdul Razack. Oral Drug Treatments in Subjects with Erectile Dysfunction and Multiple Comorbidities: A Retrospective Observational Study. BMJ Open;4(7)2014 - doi:10.1136/bmjopen-2014-005381 (WoS)
    • Hasniza Zaman Huri, Vishaaliny Permalu, Shireene Ratna Vethakkan. Sliding-scale versus basal-bolus insulin in the management of severe or acute hyperglycemia in type 2 diabetes patients: A retrospective study. PLos ONE (accepted) (WoS)
    • Hasniza Zaman Huri, NorFarahen Selamat, Shireene Ratna Vethakkan. Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Retrospective Study. Int J Endocrinol. 2014: 367564. Published online Sep 2, 2014. doi: 10.1155/2014/367564 (WoS)
    • Darfizzi Derawi,Bashar Mudhaffar Abdullah, Hasniza Zaman Huri,Rahimi M. Yusop, Jumat Salimon, Nany Hairunisa. Palm Olein as Renewable Raw Materials for Industrial and Pharmaceutical Products Applications: Chemical Characterization and Physicochemical Properties Studies; Advances in Materials Science and Engineering (accepted) (WoS/SCOPUS)
    • Mohamad Hafizi Abu Bakar, Mohamad Roji Sarmidi, Cheng Kian Kai, Hasniza Zaman Huri, Harisun Yaakob. Amelioration of Mitochondrial Dysfunction- induced Insulin Resistance in Differentiated 3T3-L1 Adipocytes via Inhibition of NF-κB Pathways. International Journal of Molecular Sciences 2014 (accepted) (WoS/SCOPUS)
    • Hasniza Zaman Huri, Lee Tze Xiang. Factors Associated With Treatment Response To Antidiabetic Agents In Compliant Type 2 Diabetes Mellitus Patients: A Brief Summary Of 5 Years' Data; Trop J Pharm Res 2014;13(3): 429-435. (WoS/SCOPUS)
    2013
    • Hasniza Zaman Huri, Ho Fun Wee. 2013,13:2. Drug Related Problems in Type 2 Diabetes Patients With Hypertension: A Cross-Sectional Retrospective Study. BMC Endocrine Disorders; doi:10.1186/1472-6823-13-2 (WoS/SCOPUS)
    • Huri, H. Z., Wee, H. F. 2013. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. Bmc Endocrine Disorders (WoS)
    • Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N, Wan Ngah WZ. Demographic and Clinical Predictors for Insulin Resistance in Type 2 Diabetes Mellitus Patients During Severe/Acute Hyperglycemia Phase. Lat. Am. J. Pharm. 32 (1): 120-7 (2013) (WoS/SCOPUS)
    • Hasniza Zaman Huri, Lee Chai Ling. Drug-Related Problems in Type 2 Diabetes Mellitus Patients with Dyslipidemia. BMC Public Health 2013, 13:1192 doi:10.1186/1471-2458- 13-1192 (WoS)
    • Sharifah Intan Qhadijah Syed Ikmal, Hasniza Zaman Huri, Shireene Ratna Vethakkan and Wan Azman Wan Ahmad. Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease; International Journal of Endocrinology 2013 (volume 2013) (WoS/SCOPUS)
    • Hasniza Zaman Huri, Vishaaliny Permalu, Nor Bahirah Kasim. Management of severe/acute hyperglycemia in hospitalised type 2 diabetes mellitus patients. Journal of Endocrinology and Diabetes Mellitus: 2013 (1)No.1: 9- 14.
    2012
    • Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N, Wan Ngah WZ. Demographic and Clinical Predictors for Insulin Resistance in Type 2 Diabetes Mellitus Patients During Severe/Acute Hyperglycemia Phase. Lat Am J Pharm (accepted) (WoS/SCOPUS)
    • Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N & Wan Ngah WZ. Optimisation of glycaemic control during episodes of severe/acute hyperglycaemia in patients with type 2 diabetes mellitus. Int J Clin Pharm (2012) 34: 863-870. (WoS/SCOPUS)
    2010
    • Hasniza ZH,Amy Tan LW Rokiah P, Che ZS, Riyanto TW. Factors influencing utilization of different types of sulphonylureas amongst type 2 diabetes patients. Lat. Am. J. Pharm. 29 (6):1044-8 (2010) (WoS/SCOPUS)
    2009
    • Zaman Huri H, Foong G, Pendek R, Teguh Widodo R .Different characteristics of diabetic ketoacidosis between type 1 and type 2 diabetes patients in Malaysia. Asian Biomedicine 2009; 3 (2): 201-206 (WoS/SCOPUS)
    • Huri HZ, Lian GTP , Hussain S, Pendek R, Widodo RT. A survey amongst Complementary Alternative Medicine (CAM) users with type 2 diabetes. International Journal of Diabetes and Metabolism, Vol 17 No.1 April 2009:9-15 (SCOPUS)
    2008
    • Hasniza Zaman Huri, Lee Qiu Yi, Rokiah Pendek, Che Zuraini Sulaiman. Utilization of antiplatelet agents for primary and secondary prevention of cardiovascular disease amongst type 2 diabetics. Journal of Pharmacy Practice, Vol. 21, No. 4, 287-301 (2008). (WoS/SCOPUS)
    • Hasniza Zaman Huri, Ong Chin Wen, Rokiah Pendek. Self- Monitoring Blood Glucose (SMBG) in type 2 diabetics in Malaysia. Asian Biomedicine, Vol 2 No.4 August 2008; 335-340. (WoS/SCOPUS)
    2007
    • Hasniza Zaman Huri, Yeap Sze Min, Rokiah Pendek. Episodes of hypoglycemia and hyperglycemia during the use of sliding scale insulin in hospitalized diabetes patients. Asian Biomedicine Vol 1 No 3 October 2007; 307-311. (WoS/SCOPUS)
    Book
    2017
    • Hasniza Zaman Huri, Chng Kiat Hui, Luqman Ibrahim (2017). Utilisation of Variable Rate Intravenous Insulin Infusion. Lambert Academic Publishing. Germany
    2015
    • Bashar Mudhaffar Abdullah, Hasniza Zaman Huri, Emad Yousif. Biolubricant Base Oil Synthesis and Its Application: Pharmaceutical and Industrial Applications Based on Enviromental Friendly. Lambert Academic Publishing, Germany 2015.
    • Bashar Mudhaffar Abdullah, Hasniza Zaman Huri, Nany Hairunisa. Hydrolysis, Separation and Purification of Fatty Acids for Bioproducts. Lambert Academic Publishing, Germany 2015.
    2012
    • PT Thomas, Asrul Akmal Shafie, Chua Siew Siang, Mohamed Azmi Ahmad Hassali, Mohamad Haniki Nik Mohamed, Hasniza Zaman Huri, Lim Chin Choon, Chua Gin Nie & Yip Sook Ying 2012. Training Manual for Pharmacists for Management of Obesity and Overweight. Malaysia Academy of Pharmacy & Malaysian Pharmaceutical Society.
    Book Chapter
    2012
    • Hasniza Zaman Huri (2012). Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease, Dyslipidemia - From Prevention to Treatment, Roya Kelishadi (Ed.), ISBN: 978-953-307-904-2, InTech.
    2011
    • Zaman Huri, H. 2011. Dyslipidemia and type 2 diabetes mellitus: Implications and role of antiplatelet agents in primary prevention of cardiovascular diseases. Dlm. Dyslipidemia (in press): In Tech Publisher
    Article in Proceedings
    2006
    • Hasniza ZH, Noorasyikin S, Reena R, Samsinah HH. Pharmacy Programme and Clinical Pharmacy Teaching in the University of Malaya, 2006. International Conference on Clinical Pharmacy Education, Japan
    Mass Media(Newspaper,Radio,TV,Popular Magazine)
    2014
    • Hasniza Zaman Huri. Continuing Professional Development (CPD): Management of the Diabetic Foot (pg 31-38). Pharmacy Today (Malaysia) - Pharmacy Practice. December 2014. Published by MIMS (Hong Kong) Limited, Asia - recognised by Academy of Pharmacy, Malaysia.
    2013
    • Hasniza Zaman Huri. Continuing Professional Development (CPD): Managing Erectile Dysfunction. Pharmacy Today (Malaysia) - Clinical Pharmacy. April 2013: 21-22. Published by MIMS Medica Pacific Limited,Asia - recognised by Academy of Pharmacy, Malaysia.
    • Hasniza Zaman Huri. Continuing Professional Development (CPD): Managing Benign Prostatic Hyperplasia. Pharmacy Today (Malaysia) - Pharmacy Practice. December 2013. Published by MIMS (Hong Kong) Limited, Asia - recognised by Academy of Pharmacy, Malaysia.
    Extended Abstract
    2021
    • Tee Khim Boon, Hasniza Zaman Huri, Najihah Mohd Hashim, Luqman Ibrahim, Mohd Zuwairi Saiman Zaril Harza Zakaria, Kasful Asra Sakika, Syaza Fatnin Hisham, Azwa Mansor. Pharmacometabolomics of Meformin Demonstrated Insulin Sensitivity Related Pathways at Peak Plasma Concentration on Healthy Volunteers Preliminary Results. Metabolism (Clinical & Experimental) 0069 | VOLUME 116, SUPPLEMENT , 154536, MARCH 01, 2021. DOI: https://doi.org/10.1016/j.metabol.2020.154536
    • Sangeetha Perumalsamy, Hasniza Zaman Huri, Wan Azman Wan Ahmad. Association of YKL-40 Encoding Gene CHI3L1 rs946263 with Insulin Resistance and Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus Patients. Metabolism (Clinical & Experimental) 0053 | VOLUME 116, SUPPLEMENT , 154520, MARCH 01, 2021. DOI: https://doi.org/10.1016/j.metabol.2020.154520
    2016
    • NAVIN K. LOGANADAN, HASNIZA ZAMAN HURI, SHIREENE R. VETHAKKAN, ZANARIAH HUSSEIN. Association of rs5219 KCNJ11 Gene Polymorphism with Pancreatic Beta-Cell Function, Insulin Resistance, and Glycemic Control of Sulfonylurea-treated Malaysian Type 2 Diabetes Patients. Diabetes (American Diabetes Association) 2016: A428 (WoS)
    2015
    • Navin Kumar Loganadan, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Zanariah Hussein. Association Between Pancreatic Beta Cell Function and Glycemic Control of Type 2 Diabetes Patients on Maximal Sulphonylurea Therapy. Journal of the ASEAN Federation of Endocrine Societies 2015. 30 (2): 101.
    • Jazlina Liza Jamaluddin, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Norlaila Mustafa. The association of WFS1 gene polymorphisms with the DPP-4 inhibitors treatment response in type 2 diabetes.J Diab Metab 6: 10.
    • Maryam Abbaspour Babaei, Hasniza Zaman Huri, Behnam Kamalidehghan. Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis induces apoptosis through activation of intrinsic, extrinsic and NF- B signaling pathways on human prostate cancer PC3 cells in vitro
    2012
    • Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N, Wan Ngah WZ. Predictors for type 2 diabetes mellitus duringsevere/acute hyperglycemic phase. Abstract; 1st APCEEBM.
    2011
    • H. Zaman Huri M. Makmor-Bakry, R. Hashim, N. Mustafa and WZ. Wan Ngah.Optimizing glycemic control during severe/acute hyperglycemic phase in type 2 diabetes patients: From predictors to a new approach. Abstract Book, Diabetes Asia 2011 Conference: 48
    2008
    • Riyanto Teguh Widodo, Hasniza Zaman Huri. (2008). Saliva Stimulating Tablets. 17th International Invention Innovation Industrial Design & Technology Exhibition 2008, KL-Malaysia 19-21 May 2008 (Non-WoS/Non-SCOPUS)
    2007
    • Hasniza Zaman Huri, Ong Chin Wen, Rokiah Pendek \"A survey about Self Monitoring Bloog Glucose amongst type 2 diabetes outpatients\", 2007, 14th Congress of ASEAN Federation of Endocrine Societies (AFES) 2007,
    • Riyanto Teguh Widodo, Samsinah Haji Hussain, Mohd Amin Jalaluddin, Hasniza Zaman Huri. Multipurpose liquid artificial saliva formulations. 2007. SMIDEX
    RESEARCH PROJECT
    (Project title),(Role),(Duration),(Level)
    Private Funding
  • Diabetes and Cardiometabolic Research, Consultant, 2020 - 2022 (National)
  • Fundamental Research Grant Scheme (FRGS)
  • Metabolic mechanism of inter-tissue crosstalk for excess nutrient flux in the biofluids of Type 2 Diabetes (T2D) individuals using an integrated multi-omics approach, Consultant, 2019 - 2022 (National)
  • Metabolic Mechanism of Reactive Oxygen Species induced Inflammation in Type 2 Diabetes, Consultant, 2013 - 2015 (National)
  • Saliva stimulating tablets formulations , Consultant, 2006 - 2009
  • Impact Oriented Interdisclipinary Research Grant (IIRG)
  • Pharmacometabolomics of Registered Andrographis Paniculata in Plasma and Urine, Programme Leader, 2019 - 2021 (International)
  • Geran Penyelidikan Universiti Malaya (UMRG)
  • CLINICAL AND GENETIC PREDICTORS FOR SULPHONYLUREA RESPONSE IN MALAYSIAN TYPE 2 DIABETES PATIENTS , Principal Investigator(PI), 2014 - 2015 (National)
  • Clinical and genetic markers of DPPIV inhibitors treatment response in type 2 diabetes mellitus patients , Principal Investigator(PI), 2012 - 2014 (National)
  • ScienceFund
  • Impact of PAX4 genes mutation on sitagliptin treatment response in type 2 diabetes mellitus patients. , Principal Investigator(PI), 2012 - 2014 (International)
  • Postgraduate Research Grant(PPP)
  • Genetic Markers of Oral Incretin-Based Therapy Response in Type 2 Diabetes Mellitus , Principal Investigator(PI), 2012 - 2014 (National)
  • none
  • The use of self monitoring of blood glucose (SMBG) among type 2 diabete patients, Principal Investigator(PI), 2006 - 2007
  • Utilization of antiplatelet for prevention of cardiovascular disease in diabetes patients , Principal Investigator(PI), 2006 - 2007
  • Characteristics of diabetes ketoacidosis (DKA) among type 2 diabetes patients , Principal Investigator(PI), 2006 - 2007
  • Use of sulphonylureas in type 2 diabetes patients, Principal Investigator(PI), 2006 - 2007
  • The use of antihypertensive agents among diabetes patients, Principal Investigator(PI), 2005 - 2006
  • Use of Complementary alternative medicines (CAMs) for type 2 diabetes patients , Principal Investigator(PI), 2005 - 2006
  • SUPERVISION
    Academic Adviser
    (Total of Student),(No. of Contact Hours),(Academic Session)
  • 80, 16, 2011/2012
  • 45, 15, 2005/2006
  • 90, 18, 2012/2013
  • 60, 14, 2013/2014
  • 75, 14, 2014/2015
  • 90, 18, 2015/2016
  • 130, 13, 2017/2018
  • External Supervision
    (Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
    Completed
    • Metabolic Profiling of Urine and Blood Samples from Healthy Volunteers, Impaired Fasting Glucose and Type 2 Diabetic Patients Using Ultra Performance Liquid Chromatography (LC)-QTRAP MS (passed with distinction), Mohamad Hafizi Abu Bakar, M0100105 (Post Graduate Student)
    • Assessment of Prescribing Pattern of Statins in Malaysian Type 2 Diabetes Patients: Pre vs Post Educational Intervention, Mohamed Hasan Abdelaziz Elnaem, M0100106 (Post Graduate Student)
    Postgraduate Student
    (Title of Thesis),(Name of Candidates),(Institution),(Academic Level)
    Ongoing
    • Adherence to prophylaxis regimen and bleeding disorder in haemophilia, FADZLIN MOHD MOKHTAR, University of Malaya (UM) (Post Graduate Student)
    • -, NAVA YUGAVATHY A/P SELVARAJA, University of Malaya (UM) (Post Graduate Student)
    • Potential Clinical and Genetic Predictors of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease (CAD), Sangeetha Perumalsamy, University of Malaya (UM) (Post Graduate Student)
    • Treatment Pattern and Outcome of Lupus Nephritis in Malaysia, Esra Nasraldin Khalil Sharafaldin, University of Malaya (UM) (Post Graduate Student)
    • ASSESSMENT OF SHARED DECISION MAKING IN THE PHARMACOLOGICAL MANAGEMENT OF MAJOR DEPRESSIVE DISORDER: TOWARDS A PATIENT, PHYSICIAN AND PHARMACIST CENTRED APPROACH, AYA AHMED ABOUSHEISHAA, University of Malaya (PhD)
    • ELUCIDATION OF MEDICATION ADHERENCE AND ECONOMIC EVALUATION OF CLOTTING FACTORS IN HAEMOPHILIA MANAGEMENT, FADZLIN BINTI MOHD MOKHTAR, University of Malaya (PhD)
    • A COMPREHENSIVE STUDY FOR THE MAJOR OBSTACLE OF THE PROMISING PERITONEAL DIALYSIS PROGRAM, Esra Nasraldin Khalil Sharafaldin, University of Malaya (PhD)
    • CLINICAL AND GENETIC MARKERS ASSOCIATED WITH ERYTHROPOIETIN DEFICIENCY ANAEMIA AND ERYTHROPOETIN STIMULATING AGENT TREATMENT RESPONSE IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS, NAVA YUGAVATHY A/P SELVARAJA, University of Malaya (PhD)
    • Comparing Health-Related Quality of Life (HRQoL) between male diabetic patients and female diabetic patients with Diabetic Foot Ulcers (DFUs), Idris Omotosho, University of Malaya (MASTER)
    • Phase 1 Clinical Trial: Bioavailability and Pharmacokinetics Study: Integration of Pharmacometabolomics into Pharmacokinetics and Pharmacodynamics for Orthosiphonaristatus (MisaiKucing) and Glibenclamide in Healthy Volunteers, Tee Khim Boon, University of Malaya (UM) (Post Graduate Student)
    • Clinical and Genetic Markers of EPO Deficiency Anemia in CKD Patients, Nava Yugavathy, University of Malaya (UM) (Post Graduate Student)
    • Association Between the Antihyperglycemic Agents, Glycemic Control and Antibiotic Therapy with the Severity of Diabetic Foot Ulcers Among Type 2 Diabetes, Idris Ajibola Omotosho, University of Malaya (UM) (Post Graduate Student)
    • Association of Effect of Using Antipsychotic Medications and Glycemic Control Among Malaysian Type I & II Diabetes Mellitus Patients, Aya Ahmad Abousheishae, University of Malaya (UM) (Post Graduate Student)
    • ASSOCIATION OF ANTIHYPERGLYCEMIC REGIMENS WITH GLYCAEMIC CONTROL AND CARDIOVASCULAR OUTCOMES IN HEART FAILURE PATIENTS, LIN SHU NING, University of Malaya (UM) (Post Graduate Student)
    • -, TEE KHIM BOON, University of Malaya (UM) (Post Graduate Student)
    • , TEE KHIM BOON, University of Malaya (PhD)
    Completed
    • Association of Genetic Polymorphisms of Dipeptidyl Peptidase-4 with Type 2 Diabetes and Metabolic Syndrome In Malaysian Population (passed with distinction), Radwan Hamoud Ali, University of Malaya (UM) (Post Graduate Student)
    • Cost Effectiveness of a Pharmacist Telemonitoring Programme for Antidepressant Use, SYAHRIR BIN ZAINI, University of Malaya (UM) (Post Graduate Student)
    • CLINICAL AND GENETIC ASSOCIATIONS OF INSULIN RESISTANCE AND SEVERITY OF CORONARY ARTERY DISEASE (CAD) IN TYPE 2 DIABETES (T2D) PATIENTS., SANGEETHA A/P PERUMALSAMY, University of Malaya (PhD)
    • A STUDY ON THE EFFECTS OF ANTIHYPERGLYCAEMIC DRUGS AND GLYCAEMIC CONTROL ON LEFT VENTRICULAR EJECTION FRACTION IN HEART FAILURE PATIENTS WITH TYPE 2 DIABETES, LIN SHU NING, University of Malaya (MASTER)
    • ENABLING PATIENT-CENTRED CARE AND ENGAGEMENT THROUGH SHARED DECISION MAKING IN ANTIDEPRESSANT USE AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER., SYAHRIR BIN ZAINI, University of Malaya (PhD)
    • Glycemic control in Type 2 Diabetes Mellitus among Simvastatin User, Nor Razida binti Razali, University of Malaya (UM) (Post Graduate Student)
    • Genetic Markers in Uncontrolled Type 2 Diabetes Mellitus Patients with Obesity, Nur Bahirah Kasim, University of Malaya (UM) (Post Graduate Student)
    • Clinical and Genetic Predictors of Sulphonylureas Among Malaysian Type 2 Diabetes Patients, Navin Kumar Loganadan, University of Malaya (UM) (Post Graduate Student)
    • Natural Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis, Exhibits Apoptogenic Properties in human prostate cancer cell (PC3) via Induction of intrinsic, extrinsic apoptosis pathways and inhibition of NF- B signaling pathway, an in-vitro study, MARYAM ABBASPOUR BABAEI, University of Malaya (UM) (Post Graduate Student)
    • Association of Biomarkers with Comorbidities, Drug Treatments and Psychological Factors in Patients with Erectile Dysfunction, Raymond Mark Joseph, University of Malaya (UM) (Post Graduate Student)
    • Clinical and Genetic Associations of DPPIV Treatment Response in Type 2 Diabetes Patients, Jazlina Liza Dato' Jamaluddin, University of Malaya (UM) (Post Graduate Student)
    Other
    • ASSOCIATION OF ADHERE TO PROPHYLAXIS TREATMENT WITH BLEEDING RATE AND CO-MORBIDITY AMONG SEVERE HEMOPHILIA A PATIENT, FADZLIN BINTI MOHD MOKHTAR, University of Malaya (MASTER)
    UG Student/Clinical Fellowship
    (Title of Thesis),(Academic Session)
    Completed
    • CLINICAL CHARACTERISTICS AND MANAGEMENT OF THYROID DISORDERS IN UMMC, 2019/2020
    • Association of Clinical Factors, Anemia and Treatment Response in Pre-Dialysis Chronic Kidney Disease Patients, 2017/2018
    • ANTIHYPERTENSIVES UTILIZATION IN TYPE 2 DIABETES PATIENTS IN UMMC, 2019/2020
    • Drugs related problems in type 2 diabetes patients with acute hyperglycemia, 2014/2015
    • Drug Related Problems in Patient with Chronic Kidney Disease, 2017/2018
    • Survey on the use of complementary alternative medicines (CAM) in type 2 diabetes patients, 2014/2015
    • Drug Related Problems in Patient with Rheumatoid Arthritis, 2017/2018
    • Glycemic Control and Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease, 2017/2018
    • Students' Readiness For Interprofessional Learning (IPL) in Cyberjaya University College of Medical Science (CUCMS), 2018/2019
    • Glycemic Control and Antidiabetic Drugs in Type 2 Diabetes Patients with Chronic Glucocorticoid Therapy, 2018/2019
    • Glycemic Control and Antidiabetic Drugs in Type 2 Diabetes Patients with Overweight and Obesity, 2018/2019
    • Drug Related Problems in Type 2 Diabetes Patients with Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State, 2018/2019
    • Assessment of Factors Associated with Attainment of Glycemic Control in Type 2 Diabetes Patients, 2018/2019
    • Incidence of Depression among Undergraduate Pharmacy Students in Malaysia, 2018/2019
    • A study of Antihypertensives Use in Diabetic Hypertensive Patients In a Teaching Hospital, 2005/2006
    • Factors Associated with Erythropoietin Stimulating Agents (ESAs) treatment response in Chronic Kidney Disease, 2016/2017
    • A survey of diabetes self management in type 2 diabetes management glycemic control, 2014/2015
    • Survey on self-monitoring of blood glucose (SMBG) and sick day management in patients with type 2 diabetes, 2015/2016
    • A study on glycaemic control and antidiabetic drugs in type 2 diabetes mellitus patients with diabetic foot complications, 2014/2015
    • Drugs related problems in type 2 diabetes patients with acute hyperglycemia, 2015/2016
    • Drug related problems in type 2 diabetes patients with cardiovascular disease, 2015/2016
    • Glycaemic control and antidiabetic drugs in type 2 diabetes mellitus patients with diabetic foot complications, 2015/2016
    • Survey on the use of complementary alternative medicines (CAM) in type 2 diabetes patients, 2015/2016
    • Insulin treatment in type 2 diabetes mellitus patients with coronary artery disease, 2016/2017
    • Medication errors analysis in University Malaya Medical Centre (UMMC) Inpatient Pharmacy, 2016/2017
    • Utilisation of antiplatelet among diabetes patients, 2006/2007
    • ASSOCIATION OF ATORVASTATIN WITH LIPID PARAMETER AND GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS IN UMMC, 2019/2020
    • Utilisation of sliding scale insulin in type 2 diabetes mellitus patients during severe/acute hyperglycemia, 2014/2015
    • Drug-related problems in patients with erectile dysfunction and multiple comorbidities, 2014/2015
    • Drug-related problems in patients with benign prostatic hyperplasia, 2012/2013
    • Comparison of efficacy and safety of a fixed versus variable dose regimen of intravenous insulin in type 2 diabetes patients, 2014/2015
    • Glycaemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications., 2013/2014
    • Glycaemic control and antidiabetic drugs in type 2 diabetes mellitus patients with diabetic retinopathy, 2013/2014
    • Glycaemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications, 2013/2014
    • A retrospective study on hypoglycemia episodes in hospitalised type 2 diabetes mellitus patients, 2012/2013
    • Characteristics and management of patients with erectile dysfunction, 2012/2013
    • Management of severe/acute hyperglycaemia in hospitalised type 2 diabetes patients, 2012/2013
    • Drug related problems in type 2 diabetes patients with cardiovascular disease, 2014/2015
    • Utilization of sliding scale insulin in an endocrine ward, 2006/2007
    • Utilisation of sulphonylureas amongst type 2 diabetic, 2006/2007
    • A survey of SMBG amongst type II diabetics, 2006/2007
    • Drug-related problems in type 2 diabetes patients with dyslipidemia, 2011/2012
    • A study on response to diabetes medications in type 2 diabetes mellitus patients, 2011/2012
    • Drugs-related problems in hospitalized type 2 diabetes patients, 2011/2012
    • Drug-related problems in type 2 diabetes patients with hypertension, 2011/2012
    • A survey on psychological factors, patients knowledge and drug treatments amongst patients with erectile dysfunction, 2013/2014
    • Utilisation of DPP4-inhibitor in type 2 diabetes mellitus patients, 2012/2013
    • Comparison of efficacy and adverse effects of human insulin and analogue insulin among diabetes mellitus patients with multiple comorbidities, 2014/2015
    • Cardiovascular events and glycemic control in type 2 diabetes mellitus patients treated with statins, 2014/2015
    • Complementary and Alternative Medicine Use Among Adults Diabetes with diabetes, 2005/2006
    • GLYCEMIC CONTROL AND ANTIDIABETIC DRUGS IN TYPE 2 DIABETES PATIENTS WITH CHRONIC THIAZIDES DIURETIC THERAPY IN UMMC, 2019/2020
    • A study of Diabetic Ketoacidosis (DKA) in adult patients with diabetes mellitus, 2005/2006
    • A study on The Use Of Sliding Scale Insulin In An Endocrine Ward, 2005/2006
    SOCIAL RESPONSIBILITY ACTIVITIES
    (Contribution to Society),(Duration),(Level)
    • IPSF StudentS Exchange Program 2017 - Supervise two(2) Pharmacy International Students for a research project , 17/07/2017 to 28/07/2017
    • Organizing Committee (Coordinator for theme 2: pill to heal)- Faculty of Medicine Research Week (FOMRW) 2015 , 11/05/2015 to 15/05/2015
    • Organizing Committee (Treasurer)- Faculty of Medicine Research Week (FOMRW) 2015 , 11/05/2015 to 15/05/2015
    • Organizing Committee (Sponsorship)- Faculty of Medicine Research Week (FOMRW) 2015, 11/05/2015 to 15/05/2015
    • Organizing Committee (sponsorship) of the Golden Helix Symposium 2015. , 11/03/2015 to 13/03/2015
    • Organizing Committee of the UM-LMIF Short Course on Translational Medicine, 08/12/2014 to 12/12/2014
    • Organising Committee: Good Clinical Practice (GCP) Workshop, 08/04/2014 to 10/04/2014
    • Organiser (Registration): Opening Ceremony of Research Week in commemoration of 50th Anniversary Celebration Faculty of Medicine, University of Malaya, 21/01/2013 to 23/01/2013
    • 11th MPS Pharmacy Scientific Conference 2012 (MPS-PSC 2012) [Head of Registration Committee], 30/10/2012 to 02/11/2012
    • 11th MPS Pharmacy Scientific Conference 2012 (MPS-PSC 2012) [Secretary II], 30/10/2012 to 02/11/2012
    • Founder of Pharmacy Alumni Society, University of Malaya (PhAUM), 2012
    • Founder of a new student award for UM Pharmacy students (Icon of UM's Pharmacy Students 2012), 2012
    • MPS Scientific Conference 2006 (Head Of Registration Committee), 01/09/2006 to 03/09/2006
    ACADEMIC/PROFESSIONAL SERVICES
    Academic/Professional Services
    (Contribution),(Duration),(Level),(Role)
  • External Examiner for a PhD thesis (USM), 18/04/2022 to 31/12/2022, National, (External Examiner)
  • Committee Member for Joint Technical Committee, Pharmacy Board Malaysia, 01/04/2022 to 31/03/2025, National, (Expert Advisor)
  • Keynote Speaker, 26/03/2022 to 27/03/2022, International, (Panelist/Moderator)
  • Speaker for International Conference on Advances of Pharmaceutical and Health Sciences, 25/03/2022 to 26/03/2022, International, (Panelist/Moderator)
  • External Examiner for Bachelor of Pharmacy (Honours) - Semester 6, 07/03/2022 to 09/04/2022, National, (External Examiner)
  • External Examiner for a Master of Medical Sciences candidate, 14/02/2022 to 07/03/2022, National, (External Examiner)
  • Editorial Board, 04/01/2022 to 31/12/2024, International, (Expert Advisor)
  • Research Committee for the Direction of Pharmacy Education in Malaysia, 03/11/2021 to 03/05/2022, National, (Expert Advisor)
  • Editorial Board for Panacea, 04/10/2021 to 31/12/2022, University, (Reviewer)
  • External examiner to a Master of Science's student (UKM), 21/08/2021 to 30/09/2021, National, (External Examiner)
  • External Examiner to a Master Student (UNIMAS), 20/08/2021 to 20/09/2021, National, (External Examiner)
  • External Examiner to a PhD student, 03/08/2021 to 31/01/2022, National, (External Examiner)
  • External Examiner - Master of Pharmacy Practice, 02/08/2021 to 20/08/2021, National, (External Examiner)
  • Review an article, 12/07/2021 to 25/07/2021, International, (Reviewer)
  • External Examiner for a Master Thesis (USM), 06/07/2021 to 14/08/2021, National, (External Examiner)
  • Review a journal article (June 2021), 23/06/2021 to 03/07/2021, International, (Reviewer)
  • Judge for National Pharmacist Convention 2021, 14/06/2021 to 20/06/2021, National, (External Evaluator)
  • Head of Organising Committee for Pharmacy Dean Council Award 2021, 01/06/2021 to 21/01/2022, National, (Expert Advisor)
  • Jury Member for International Innovation Awards 2021, 22/03/2021 to 26/03/2021, International, (External Evaluator)
  • Reviewer of manuscript (March 2021), 17/03/2021 to 31/05/2021, International, (Reviewer)
  • Review of an article - World Journal of Diabetes, 29/01/2021 to 20/02/2021, International, (Reviewer)
  • REVIEWER FOR DRUG, HEALTHCARE AND PATIENT SAFETY (JANUARY 2021), 26/01/2021 to 06/02/2021, International, (Reviewer)
  • Reviewer for Journal of Diabetes and Clinical Practice, 20/01/2021 to 10/02/2021, International, (Reviewer)
  • External Examiner for Bachelor of Pharmacy (Hons), 01/01/2021 to 31/12/2023, National, (External Assessor)
  • Evaluation Activity
    (Activity),(Duration),(Category)
  • Reviewer for abstracts: 11th Malaysian Pharmaceutical Society-Pharmacy Scientific Conference 2012 (31st Oct-2nd Nov 2012) ,   (Abstracts)
  • The Ad-Hoc Committee to evaluate and review the application of Masters of Medical Sciences, University of Malaya for candidate Kanagamalar a / p Subramaniam. ,   (Project)
  • The viva voce and thesis examination for Bachelor of Pharmacy (Hons), The National University of Malaysia for candidate Liew Mei Yao. ,   (External Examiner)
  • The Ad-Hoc Committee to evaluate and review the application of Masters of Medical Sciences, University of Malaya for candidate Yvonne Khoo Siew Khoon. ,   (Project)
  • The viva voce and thesis examination for Master of Clinical Pharmacy, The National University of Malaysia for candidate Rozita Mohamad. ,   (External Examiner)
  • The Ad-Hoc Committee to evaluate and review the application of Masters of Medical Sciences, University of Malaya for candidate Laith N. Zaki. ,   (Project)
  • The viva voce and thesis examination for Bachelor of Pharmacy (Hons), The National University of Malaysia for candidate Choy Wan Ru. ,   (External Examiner)
  • The viva voce and thesis examination for Bachelor of Pharmacy (Hons), The National University of Malaysia for candidate Farrah Idayu Zakaria. ,   (External Examiner)
  • The viva voce and thesis examination for Bachelor of Pharmacy (Hons), The National University of Malaysia for candidate Lee Pooi Mun. ,   (External Examiner)
  • The viva voce and thesis examination for Master of Clinical Pharmacy, The National University of Malaysia for candidate Neesa Kamarun Begum Mohd Kassim. ,   (External Examiner)
  • Reviewer; International Journal of Diabetes Research (February 2013) ,   (Article in Journal)
  • Reviewer - Brazilian Journal of Pharmaceutical Sciences (ISI-indexed) - September 2017 ,   (Article in Journal)
  • Reviewer - Clinical Drug Investigation (August 2018) ,   (Article in Journal)
  • The viva voce and thesis examination for Bachelor of Pharmacy (Hons), The National University of Malaysia for candidate Ng Cheah Phing.,   (External Examiner)
  • Reviewer for Gene Reports (June 2021) , 2021 to 2021 (Article in Journal)
  • Reviewer for European Journal of Clinical Investigation (WOS Indexed) - March 2021, 2021 to 2021 (Article in Journal)
  • Reviewer for Drug, Healthcare and Patient Safety (January 2021), 2021 to 2021 (Article in Journal)
  • Reviewer for Diabetes Research and Clinical Practice (ISI-indexed) - January 2021 , 2021 to 2021 (Article in Journal)
  • Reviewer - World Journal of Diabetes (January 2021) - ISI-Indexed , 2021 to 2021 (Article in Journal)
  • Reviewer for Canadian Journal of Diabetes (October 2020 ) -ISI-indexed , 2020 to 2020 (Article in Journal)
  • External Examiner for Master in Pharmacy Practice (International Medical University), 2020 to 2021 (Thesis)
  • Reviewer for Expert Review of Endocrinology & Metabolism (October 2020) , 2020 to 2020 (Article in Journal)
  • Reviewer for Drug, Healthcare and Patient Safety (October 2020), 2020 to 2020 (Article in Journal)
  • Reviewer for International Journal of Diabetes in Developing Countries (JDCC) -August 2020 (ISI-indexed) , 2020 to 2020 (Article in Journal)
  • Reviewer - International Journal of Diabetes in Developing Countries (July 2020) , 2020 to 2020 (Article in Journal)
  • Reviewer: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy (April 2020) -ISI-indexed, 2020 to 2020 (Article in Journal)
  • Manuscript review -Risk Management and Healthcare Policy ( February 2020) , 2020 to 2020 (Article in Journal)
  • Reviewer - Clinical Nutrition ESPEN (ISI-cited) February 2020 , 2020 to 2020 (Article in Journal)
  • Reviewer - BMC Medical Genetics (January 2020) , 2020 to 2020 (Article in Journal)
  • External Examiner for a Master's thesis , 2020 to 2021 (Thesis)
  • Reviewer for Malaysian Journal of Medical Sciences , 2020 to 2021 (Article in Journal)
  • Assessor for a phD application (July 2019), 2019 to 2019 (Project)
  • Reviewer - Clinical Nutrition ESPEN (June 2019) , 2019 to 2019 (Article in Journal)
  • External Examiner for a pHD thesis - June 2019 , 2019 to 2019 (Thesis)
  • Reviewer - Journal of Integrative Medicine (May 2019), 2019 to 2019 (Article in Journal)
  • Reviewer - Journal of Clinical Pharmacy and Therapeutics - ISI-indexed (April 2019), 2019 to 2019 (Article in Journal)
  • Oral and thesis examiner for MIC 4005 Research in Biomedical Science , 2019 to 2019 (Thesis)
  • Reviewer - Primary Care Diabetes - ISI-indexed (March 2019), 2019 to 2019 (Article in Journal)
  • Reviewer - PeerJ - ISI-indexed (March 2019), 2019 to 2019 (Article in Journal)
  • Reviewer for Plos One (ISI-indexed) - March 2019 , 2019 to 2019 (Article in Journal)
  • Reviewer - Primary Care Diabetes (ISI-indexed) - March 2019, 2019 to 2019 (Article in Journal)
  • Reviewer for Primary Care Diabetes (ISI-Indexed) - February 2019 , 2019 to 2019 (Article in Journal)
  • Reviewer, Indian Journal of Pharmaceutical Education and Research (ISI-indexed) -January 2019 , 2019 to 2019 (Article in Journal)
  • Assessor for a Master Application (January 2019) , 2019 to 2019 (Project)
  • Reviewer; International Journal of Clinical Pharmacy (ISI-indexed) - January 2019, 2019 to 2019 (Article in Journal)
  • External Examiner for Doctor of Pharmacy (PharmD) Program , 2018 to 2018 (Thesis)
  • Reviewer - The Pharmacogenomics Journal, 2018 to 2018 (Article in Journal)
  • Assessor for Candidature Defence for a Master Candidate (01.10.2018) , 2018 to 2018 (Thesis)
  • Reviewer - Journal of Diabetes (ISI-indexed journal) - June 2018 , 2018 to 2018 (Article in Journal)
  • Reviewer - BMJ Open (ISI-cited) - February 2018 , 2018 to 2018 (Article in Journal)
  • Reviewer for Clinical Immunology, Endocrine & Metabolic Drugs (April 2018), 2018 to 2018 (Article in Journal)
  • Reviewer for Family Medicine and Community Health (April 2018), 2018 to 2018 (Article in Journal)
  • Reviewer - BMC Endocrine Disorders (ISI-cited) - April 2018, 2018 to 2018 (Article in Journal)
  • Reviewer - Biomarkers in Medicine (ISI-indexed) - March 2018 , 2018 to 2018 (Article in Journal)
  • Reviewer- BMC Cardiovascular Disorders (ISI-indexed) - March 2018 , 2018 to 2018 (Article in Journal)
  • Reviewer - Journal of Clinical Nursing (ISI-cited) - March 2018, 2018 to 2018 (Article in Journal)
  • Reviewer - Current Diabetes Reviews (March 2018) , 2018 to 2018 (Article in Journal)
  • Reviewer - Journal of Clinical Pharmacy & Therapeutics (February 2018) , 2018 to 2018 (Article in Journal)
  • Evaluator for grant application, 2018 (Project)
  • Assessor for Candidature Defence (February 2018), 2018 to 2018 (Project)
  • Reviewer - Brazilian Journal of Pharmaceutical Sciences - ISI cited (September 2017) , 2017 to 2017 (Article in Journal)
  • Reviewer - Journal of Diabetes Investigation - ISI-indexed (February 2017) , 2017 to 2017 (Article in Journal)
  • Reviewer - BMJ Open (ISI-indexed) - October 2017 , 2017 to 2017 (Article in Journal)
  • Grant Evaluator - October 2017 , 2017 to 2017 (Project)
  • Reviewer - Plos One (ISI-indexed) - October 2017 , 2017 to 2017 (Article in Journal)
  • Reviewer - Diabetic Medicine (ISI-indexed) - October 2017 , 2017 to 2017 (Article in Journal)
  • Reviewer - Endocrinology, Diabetes and Metabolism Case Reports - ISI-indexed (January 2017) , 2017 to 2017 (Article in Journal)
  • External Examiner for one student - Master of Clinical Pharmacy -CUCMS (September 2017) , 2017 to 2017 (Thesis)
  • Grant Evaluator (July 2017), 2017 to 2017 (Project)
  • Reviewer for a manuscript-Genetic Testing and Molecular Biomarkers (ISI-Indexed) - June 2017 , 2017 to 2017 (Article in Journal)
  • External examiner for one student- Master of Clinical Pharmacy (CUCMS) - March 2017, 2017 to 2017 (Thesis)
  • Reviewer: BMC Research Notes (February 2017), 2017 to 2017 (Article in Journal)
  • Reviewer - Brazilian Journal of Pharmaceutical Sciences - ISI cited (January 2017), 2017 to 2017 (Article in Journal)
  • Candidature Defence for a Master Project - February 2017, 2017 to 2017 (Thesis)
  • Reviewer: American Journal of Medicine and Medical Sciences (February 2017), 2017 to 2017 (Article in Journal)
  • External Examiner for thesis evaluation for 2 students under the program of Bachelor of Pharmacy - CUCMS, 2017 to 2017 (Thesis)
  • Reviewer; BMC Endocrinology (August 2016), 2016 (Article in Journal)
  • Evaluator for a Master project application (August 2016), 2016 (Project)
  • Expert Panel for Development of Clinical Pharmacy Specialist in Malaysia - Pharmaceutical Services Divisions, Ministry of Health, Malaysia., 2016 (Development of Clinical Pharmacy Specialist)
  • Reviewer; American Journal of Medicine and Medical Sciences (July 2016), 2016 (Article in Journal)
  • Reviewer; Journal of Pediatric Endocrinology and Metabolism (JPEM) - ISI (May 2016), 2016 (Article in Journal)
  • Reviewer; British Journal of Pharmaceutical Research (May 2016), 2016 (Article in Journal)
  • Reviewer; International Journal of Diabetes Research (May 2016), 2016 (Article in Journal)
  • Reviewer; BMC Complementary and Alternative Medicine (ISI)-January 2016 , 2016 (Article in Journal)
  • Reviewer; Canadian Journal of Diabetes (ISI) - February 2016 , 2016 (Article in Journal)
  • Reviewer; BMC Complementary and Alternative Medicine (ISI)- April 2016, 2016 (Article in Journal)
  • Reviewer; BMC Complementary and Alternative Medicine (ISI) - March 2016 , 2016 (Article in Journal)
  • Reviewer; Postgraduate Medicine (ISI) - March 2016 , 2016 (Article in Journal)
  • Reviewer; BMC Cardiovascular Disorders (ISI) - February 2016 , 2016 (Article in Journal)
  • Reviewer; British Journal of Medicine and Medical Research (February 2016), 2016 (Article in Journal)
  • Reviewer; International Journal of Applied Psychology (February 2016), 2016 (Article in Journal)
  • Reviewer; British Journal of Medicine and Medical Research (January 2016), 2016 (Article in Journal)
  • Examiner for a Master thesis (January 2016) , 2016 (Thesis)
  • Evaluator for a ph.D application, 2015 (Project)
  • Change of ph.D research title, 2015 (Project)
  • Ph.D proposal presentation, 2015
  • Evaluator for a ph.D application, 2015 (Project)
  • Moderator for a Master Proposal Presentation, 2015 to 2015 (Master Proposal Presentation)
  • ph.D application, 2015 (Project)
  • Examiner for a Master Project (November 2015), 2015 (Thesis)
  • Reviewer; American Journal of Medicine and Medical Sciences (September 2015), 2015 (Article in Journal)
  • External evaluator for a grant application (International), 2015 to 2015 (Project)
  • External Examiner for a Master thesis - September 2015, 2015 to 2015 (Thesis)
  • Internal Examiner for a phD project - July 2015, 2015 to 2015 (Thesis)
  • Assessor for Candidature Defence(Master) MMedSc - 16 April 2015, 2015 to 2015 (Candidature Defence)
  • Moderator for MedSc proposal presentation - 28.05.2015, 2015 to 2015 (Project)
  • Reviewer; American Journal of Medicine and Medical Sciences (June 2015) , 2015 (Article in Journal)
  • Reviewer; International Journal of Diabetes Research (May 2015), 2015 (Article in Journal)
  • Reviewer; Clinical Drug Investigation (ISI) - October 2015 , 2015 (Article in Journal)
  • Reviewer; Journal of American Pharmacists Association (ISI) - February 2015 , 2015 (Article in Journal)
  • Reviewer; International Journal of Prevention and Treatment (April 2015), 2015 to 2015 (Article in Journal)
  • Reviewer; International Journal of Diabetes Research (April 2015), 2015 to 2015 (Article in Journal)
  • Reviewer; Plos One (ISI) - November 2015 , 2015 (Article in Journal)
  • Reviewer; Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy (March 2015), 2015 (Article in Journal)
  • Reviewer; BMC Research Notes (March 2014), 2015 (Article in Journal)
  • Proposal for a Master Candidate (February 2015) , 2015 (Evaluator)
  • Proposal for a phD candidate (February 2015), 2015 (Evaluator)
  • Reviewer; International Journal of Diabetes Research (February 2015), 2015 (Article in Journal)
  • Reviewer; International Journal of Diabetes Research (January 2015), 2015 (Article in Journal)
  • Reviewer; Malaysian Journal of Medical Sciences (January 2015), 2015 (Article in Journal)
  • Reviewer; American Journal of Medicine and Medical Sciences (December 2014), 2014 (Article in Journal)
  • Reviewer; International Journal of Statistics and Applications (November 2014), 2014 to 2014 (Article in Journal)
  • Reviewer; THE World Journal of Diabetes (August 2014), 2014 to 2014 (Article in Journal)
  • Assessor for Master Candidature Defence (17 December 2014) , 2014 to 2014 (Candidature Defence)
  • Reviewer; World Journal of Gastroenterology (April 2014), 2014 to 2014 (Article in Journal)
  • Reviewer; Indian Journal of Pharmaceutical Education and Research (ISI) - August 2014 , 2014 to 2014 (Article in Journal)
  • Reviewer; BMJ Case Report (ISI) - September 2014 , 2014 to 2014 (Article in Journal)
  • Reviewer; Cardiovascular Diabetology (ISI) - July 2014 , 2014 to 2014 (Article in Journal)
  • Reviewer; Indian Journal of Pharmaceutical Education and Research (ISI) - May 2014 , 2014 to 2014 (Article in Journal)
  • Reviewer; BMJ Open (ISI) - July 2014 , 2014 to 2014 (Article in Journal)
  • Reviewer; Indian Journal of Pharmaceutical Education and Research (ISI) - April 2014 , 2014 to 2014 (Article in Journal)
  • Reviewer; Journal of Diabetes and Metabolism, OMICS Publishing Group (February 2014) , 2014 to 2014 (Article in Journal)
  • Reviewer; Journal of Endocrinology and Diabetes Mellitus (February 2014), 2014 to 2014 (Article in Journal)
  • Reviewer; Public Health Research (January 2014), 2014 to 2014 (Article in Journal)
  • External examiner for a thesis (Master of Clinical Pharmacy); January 2014, 2014 to 2014 (Thesis)
  • Reviewer; International Journal of Diabetes Research (October 2013), 2013 to 2013 (Article in Journal)
  • Reviewer; British Journal of Pharmaceutical Research (September 2013) , 2013 to 2013 (Article in Journal)
  • Assessor for phD Candidature Defence (24 October 2013), 2013 to 2013 (Project)
  • External examiner for a thesis (Master of Clinical Pharmacy); September 2013 , 2013 to 2013 (Thesis)
  • Reviewer; Journal of Endocrinology and Diabetes Mellitus (September 2013), 2013 to 2013 (Article in Journal)
  • Reviewer; International Journal of Diabetes Research (August 2013) , 2013 to 2013 (Article in Journal)
  • Reviewer; International Journal of Surgical Research (July 2013), 2013 to 2013 (Article in Journal)
  • Reviewer; Clinical Practice (July 2013), 2013 to 2013 (Article in Journal)
  • Reviewer: Journal of Obstetrics and Gynecology (July 2013), 2013 to 2013 (Article in Journal)
  • Reviewer; International Journal of Diabetes Research (30 May 2013), 2013 (Article in Journal)
  • Reviewer; Journal of Cancer Science & Therapy (February 2013) , 2013 to 2013 (Article in Journal)
  • Reviewer; Clinical Practice (May 2013) , 2013 (Article in Journal)
  • Reviewer; Frontiers in Science (May 2013), 2013 (Article in Journal)
  • Reviewer; International Journal of Diabetes Research (April 2013) , 2013 to 2013 (Article in Journal)
  • Reviewer; American Journal of Medicine and Medical Sciences (May 2013), 2013 (Article in Journal)
  • Reviewer; Indian Journal of Pharmaceutical Education and Research (ISI)- September 2013 , 2013 to 2013 (Article in Journal)
  • External examiner for a thesis (Aini Athirah Shabudin) (Bachelor of Pharmacy); Disember 2013, 2013 to 2013 (Thesis)
  • External examiner for a thesis (Latha Devi Sukumaran) (Bachelor of Pharmacy); Disember 2013, 2013 to 2013 (Thesis)
  • Editorial Board of Mintage Journal of Pharmaceutical & Medical Sciences (2012), 2012 (Article in Journal)
  • Clinical Practice (reviewer; 2012-2014) , 2012 to 2014 (Article in Journal)
  • Journal of Health Sciences (reviewer; 2012-2014) , 2012 to 2014 (Article in Journal)
  • International Journal of Diabetes Research (reviewer; 2012-2014) , 2012 to 2014 (Article in Journal)
  • Editorial Board of Journal of Pharmacy and Pharmaceutical Sciences (Scopus-Cited)-2012 , 2012 (Article in Journal)
  • Reviewer; Journal of Health Science (October 2012) , 2012 to 2012 (Article in Journal)
  • Reviewer; American Journal of Medicine and Medical Sciences (October 2012) , 2012 to 2012 (Article in Journal)
  • Reviewer; International Journal of Diabetes Research (2012) , 2012 to 2012 (Article in Journal)
  • Reviewer; Journal of Health Sciences (2012) , 2012 to 2012 (Article in Journal)
  • American Journal of Medicine and Medical Sciences (reviewer; 2012-2014) , 2012 to 2014 (Article in Journal)
  • Reviewer: DARU J Pharm Sci (ISI)- 2012 , 2012 to 2012 (Article in Journal)
  • Editorial Board of Journal of Asian Scientific Research , 2011 (Article in Journal)
  • Expert Linkages
    (Linkages Description),(Organisation),(Duration of Involvement),(Level)
  • Judge MPS-NPC-2021 Poster, Malaysian Pharmacists Society, 2021 (National)
  • Committee Members for Development of Pharmacy Expertise via Subject Matter Expert (SME), Ministry of Health Malaysia, 2021 (National)
  • Organising Committee - Webinar of Clinical Pharmacy and Clinical Research, Allied Academies, 2021 (International)
  • Keynote Speaker - Exploring & Developing Healthcare through Innovative Clinical Pharmacy Methods -Clinical Pharmacy & Pharmacy Research 2021, Allied Academies, 2021 (International)
  • Member of ICT Steering Committee, Universiti Malaya, 2021 (University)
  • Panel of Evaluators - FRGS Grant, Taylor's University, 2021 (National)
  • Panel of Evaluators - FRGS Grant, Universiti Malaya, 2021 (University)
  • Member of Asian Council of Science Editors, Asian Council of Science Editors, 2021 (International)
  • International Jury Member for International Innovation Awards 2021 (IIA 2021), The International Expo on Innovation and Technology, 2021 (International)
  • UM Health Task force (Strategic Initiatives, Governance Model and Processes), UM Health, 2020 (University)
  • Pharmacy Dean's Council Committees, Pharmacy Dean council, 2020 (National)
  • Board Member for Akademi Pengajian Melayu, Universiti Malaya, Universiti Malaya, 2020 (University)
  • Editorial Board- Malaysian Journal of Pharmaceutical Sciences, Universiti Sains Malaysia, 2020 (International)
  • Reviewer for Swiss National Science Foundation Grant, Swiss National Science Foundation, 2020 (International)
  • Invited Speaker for UM Exclusive Webinar Series: Explore the World of Pharmaceutical Wonders with Faculty of Pharmacy, Universiti Malaya, 2020 (International)
  • Editorial Board - African Journal of Pharmaceutical Sciences, Svedberg Open, 2020 (International)
  • Speaker for Health Executive Management Programme, University Malaya Medical Centre, 2020 (National)
  • Facilitator for Impact Planning Development Workshop - IIRG Cycle 3/2020, Universiti Malaya, 2020 (University)
  • Panel of Auditors for Postgraduate Programme Accreditation, The National University of Malaysia, 2020 (National)
  • Committee Member for Evaluation of Research Funds, Ministry of Higher Education, 2020 (National)
  • Working Committee for the Consortium of Malaysian Teaching Hospital (KHUAM) for Research Cluster, Ministry of Higher Education, 2020 (National)
  • Panel of Assessors - COVID-19 Special Grants, Ministry of Higher Education, 2020 (National)
  • Permanent Member of Drug Control Authority (DCA), Ministry of Health Malaysia, 2020 (National)
  • Panel of Promotion Committee , The National University of Malaysia, 2020 (National)
  • Plenary Speaker for Shah Alam Research Day, Shah Alam Hospital, 2019 (National)
  • APPOINTMENT AS CHIEF OBJECTIVE FOR PREPARATION OF OUTCOME EVALUATION REPORT FOR EQUIPMENT PROCUREMENT OF SOUTH TOWER UNIVERSITY OF MALAYA MEDICAL CENTRE, UNIVERSITY MALAYA MEDICAL CENTRE, 2019 (National)
  • Supervise two students of Master of Regenerative Medicine for 5 weeks Industrial Attachment, University of Malaya, 2019 (University)
  • Organizing Good Clinical Practice Workshop - 6 times a year, Clinical Investigation Centre, 2019 (National)
  • Invited Speaker for UMMC Strategic Planning (Thrust 2), University Malaya Medical Centre, 2019 (University)
  • Invited Speaker for Translational Core Laboratory (TCL) Career Day, University of Malaya, 2019 (University)
  • Invited Speaker - Science Cafe August 2018, University of Malaya, 2018 (University)
  • Guest Speaker in the Bernama Today TV Program Live Show Channel 502 (Need to Know - Biosimilars) , Bernama TV, 2018 (National)
  • Guest Speaker for 'Selamat Pagi Malaysia' Program Live Show TV1 - Biosimilar, Radio Televisyen Malaysia (RTM), 2018 (National)
  • Guest Speaker -Bridging the Gap between Laboratories and Market, Innobioventures and MESTECC, 2018 (International)
  • Guest Speaker and Panelist at Innovation Forum Kuala Lumpur 2018, University of Malaya, 2018 (International)
  • Expert Opinion - Industry Stakeholders on the Master of Medical Science (Regenerative Medicine) Program, University of Malaya, 2018 (University)
  • Reviewer for Malaysian Guideline for Phase I Unit Inspection & Accreditation Programme (First Edition), National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia, 2018 (National)
  • External Examiner for Postgraduate Degree - Universiti Sains Malaysia, Universiti Sains Malaysia, 2018 (National)
  • Supervise six students of Master of Regenerative Medicine for 3 days Industrial Attachment, University of Malaya, 2018 (University)
  • Assessor for Postdoctoral Application - Auckland Medical Research Foundation (March 2018), Auckland Medical Research Foundation, 2018 (International)
  • Assessor Panel for Subject Matter Expert (SME) and SME Special Assignments (SSA) for Pharmaceutical Services Division, Ministry of Health Malaysia, Ministry of Health Malaysia, 2018 (National)
  • Assessor for Postdoctoral Application - Auckland Medical Research Foundation (September 2017), Auckland Medical Research Foundation , 2017 (International)
  • Interviewer Panel for Student Intake - Bachelor of Pharmacy (Honours), University of Malaya, 2017 (National)
  • Editorial Board Member, Diabetes and Metabolic Research, 2017 (International)
  • Search Comittee for Subject Matter Expert (SME) in Pharmacy (Permanent Member), Pharmacy Division, Ministry of Health Malaysia, 2017 (National)
  • Editorial Board Member - Universal Journal of Pharmaceutical Research, Global institute of Pharmaceutical Education and Research, Kashipur, U.K., India, 2016 (International)
  • Editorial Board Member -Austin Andrology, Austin Publishing Group, 2016 (International)
  • Editorial Board Member - Austin Renal Disorders, Austin Publishing Group, 2016 (International)
  • Expert Panel for Development of Clinical Pharmacy Specialist in Malaysia, Pharmaceutical Services Division, Ministry of Health Malaysia, 2016 (National)
  • Editorial Board Member, SM Journal of Endocrinology and Metabolism, 2015 (International)
  • Editorial Board Member, Journal of Disease Markers, Austin Publishing Group USA, 2014 (International)
  • Editorial Board - IORP Journal of Dentistry Medicine Pharmacy, IORP Journals, 2014 (International)
  • Editorial Board, Journal of Pharmaceutical and Biomedical Research, 2013 (International)
  • Editorial Board Members, Journal of Endocrinology and Diabetes Mellitus, 2013 (International)
  • Advisory Board, OA Endocrinology (OA Publishing London), 2013 (International)
  • Reviewer, Journal of Health Science, 2012 (International)
  • Reviewer, International Journal of Diabetes Research, 2012 (International)
  • Reviewer, Clinical Practice, 2012 (International)
  • Reviewer, American Journal of Medicine & Medical Sciences, 2012 (International)
  • Editorial Board, International Journal of Pharmacy and Pharmaceutical Sciences (SCOPUS-Cited), 2012 (International)
  • Editorial Board, Mintage Journal of Pharmaceutical and Medical Sciences, 2012 (International)
  • Editorial Board, Journal of Asian Scientific Research, 2011 (International)
  • Academic/Technical Contribution
    (Activity),(Organisation),(Duration),(Role)
  • Investigator Pool, University of Malaya, 2020 -  (Investigator Pool)
  • Invited Speaker for USM Pharmacy Webinar: Masking Obstacles of Scientist Mothers: Silence Epidemic Within A Pandemic, USM, 2020 - 2020 (Invited Speaker)
  • Invited Speaker - Innovation Forum: Entrepreneurship In Health Care, University of Malaya, 2018 -  (Invited Speaker)
  • Invited Speaker -Science Cafe: FOM Shared Research Facility and Services , Faculty of Medicine, 2018 - 2018 (Invited Speaker)
  • GCP Workshop October 2018, Clinical Investigation Centre (CIC), 2018 - 2018 (Project Director)
  • GCP Workshop December 2018, Clinical Investigation Centre (CIC), 2018 - 2018 (Project Director)
  • Invited Speaker - Pre-Clinical and Phase I Clinical Trials in the Cell-Based Therapy and Drug Development Workshop, National Orthopaedic Centre of Excellence in Research and Learning (NOCERAL), 2018 - 2018 (Invited Speaker)
  • GCP Workshop July 2018, Clinical Investigation Centre (CIC), 2018 - 2018 (Project Director)
  • Assessor Panel for Subject Matter Expert (SME) and SME Special Assignments (SSA) for Pharmaceutical Services Division, Ministry of Health Malaysia, Ministry of Health Malaysia, 2018 - 2020 (Expert Advisor)
  • GCP Course December 2018, Clinical Investigation Centre (CIC), 2018 - 2018 (Project Director)
  • GCP workshop March 2018, Clinical Investigation Centre, 2018 - 2018 (Project Director)
  • Interviewer Panel for New Undergraduate Students Intake; 2016, University of Malaya, 2016 - 2016
  • Exhibitor/Conference delegates for Biopharma Asia Convention 2015 , Terrapin, Singapore, 2015 - 2015 (Exhibitor/conference Delegates)
  • Interviewer Panel for New Undergraduate Students Intake; 2015 , University of Malaya, 2015 - 2015 (Interviewer Panel)
  • Invited Speaker : 45th MALAYSIAN ORTHOPAEDICASSOCIATION ANNUALSCIENTIFIC MEETING 2015- Orthopaedic Postoperative Pain Management -The Impact Of Pharmacogenomics Of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Malaysian Orthopaedic Association , 2015 - 2015 (Invited Speaker)
  • Invited Speaker for Medico-Legal Course - Roles of Clinical Investigation Centre and Phases of Clinical Trials , Exco of Teaching Hospital and Legal Advisory Council of Malaysian Public Universities, 2015 - 2015 (Invited Speaker)
  • Panel of Award Judges : 45th MALAYSIAN ORTHOPAEDIC ASSOCIATION ANNUAL SCIENTIFIC MEETING 2015, Malaysian Orthopaedic Association, 2015 - 2015 (Judges)
  • Poster Judge - Faculty of Medicine Research Week 2015 (11-15 May 2015), Faculty of Medicine, University of Malaya, 2015 - 2015 (Poster Judge)
  • JUDGE for the 44th MALAYSIAN ORTHOPAEDIC ASSOCIATION ANNUAL SCIENTIFIC MEETING 2014 MAHMOOD MERICAN AWARD, MALAYSIAN ORTHOPAEDIC ASSOCIATION, 2014 - 2014 (Judge)
  • Judge - Scientific Poster Research Competition - 13th IPSF Asia Pacific Pharmaceutical Symposium (APPS) 2014, Malaysian Pharmacy Students Association (MyPSA) and International Pharmaceutical Students Federation (IPSF) , 2014 - 2014 (Judge)
  • Curriculum Restructuring Panel Member for Postgraduate Degree for Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, 2014 - 2014 (Panel Member)
  • Interviewer Panel for New Undergraduate Students Intake; 11 Apr 14; 23-29 May 2014 , University of Malaya, 2014 - 2014 (Interviewer Panel)
  • Invited Speaker : 44th MALAYSIAN ORTHOPAEDIC ASSOCIATION ANNUAL SCIENTIFIC MEETING 2014 - Personalized Medicine --- Potential Applications to Orthopedic Practice, Malaysian Orthopaedic Association , 2014 - 2014 (Invited Speaker)
  • Judge - Taylor's University Pharmacy Student Quiz - Final round , Taylor's University, 2014 - 2014 (Judge)
  • Exhibitor/Conference delegates for Biopharma Asia Convention 2014, Terrapin Pte Ltd (Singapore) , 2014 - 2014 (Exhibitor)
  • Invited Speaker for Program Balanced Living in A Serene Campus (BLISS): Common Supplements for Women and Children, Student Empowerment Research Unit (SERU, University of Malaya, 2014 - 2014 (Invited Speaker)
  • Judge (Oral Presentations); 2nd Pharmaceutical Research Conference for Pharmacy Students & Young Graduates: 11-12th May 2013., CUCMS , 2013 - 2013 (Judge)
  • 'Conducting Clinical Trials in University of Malaya' for Research Week in commemoration of 50th Anniversary Celebration of Faculty of Medicine, University Malaya, Faculty of Medicine, University of Malaya , 2013 - 2013 (Invited Speaker)
  • Interviewer Panel for New Undergraduate Students Intake; 20-23 May 13, University of Malaya , 2013 - 2013
  • Training Module for Assistant/Research Assistant (RA): Module 3: Research Ethics used in FOM), Research Management Centre, Faculty of Medicine, University of Malaya, 2013 - 2013 (Invited Speaker)
  • Interviewer Panel for New Undergraduate Students Intake; 13 Apr 13, University of Malaya , 2013 - 2013 (Interviewer Panel)
  • Judge for oral and poster presentations at the 1st Pharmaceutical Research Conference for Pharmacy Students & Young Graduates 2012, CUCMS, 2012 - 2012
  • A night with Professors & Alumni, Orientation of New Students for Academic Year 2012/13., Faculty of Medicine, University of Malaya , 2012 - 2012 (Guest Speaker)
  • AWARD AND STEWARDSHIP
    (Name of Award/Stewardship),(Awarding Institution),(Year Awarded),(Type of Award)
    • Best Presentation in Additional Track, Monash University, 2021 (RESEARCH)
    • First Prize of the Best Oral Presentation Award, Monash University, 2021 (RESEARCH)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2020 (CERTIFICATE)
    • Members of Pharmacy Dean Council, Department of Higher Education, Ministry of Higher Education Malaysia, 2020 (SERVICES)
    • Editorial Board- Malaysian Journal of Pharmaceutical Sciences, Universiti Sains Malaysia, 2020 (RESEARCH)
    • Biography Listed in Who'S Who in The World 2020, Marquis Who'S Who in The World, 2020, Marquis Who'S Who in The World, 2020 (OTHERS)
    • Committee Member for Evaluation of Research Funds , Department of Higher Education, Ministry of Higher Education Malaysia, 2020 (RESEARCH)
    • K-Novasi 2019, National University of Malaysia, 2019 (EDUCATION)
    • Biography Listed in Who'S Who in The World 2019, Marquis Who'S Who in The World, 2019, Marquis Who's Who, 2019 (OTHERS)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2019 (CERTIFICATE)
    • Certificate of Excellent Service 2018, University of Malaya, 2019 (SERVICES)
    • 2019 Albert Nelson Marquis Lifetime Achievement Award, Marquis Who'S Who, 2019, Marquis Who'S Who, 2019 (OTHERS)
    • Certificate of Excellent Service 2017, University of Malaya, 2018 (SERVICES)
    • Certificate of Achievement of IQVIA Global Top Performing Sites (Recognition of Superior Performance and Quality for Clinical Research) for Clinical Investigation Centre (CIC) - 2017 and 2018, IQVIA, 2018 (RESEARCH)
    • Bentham Brand Ambassador, Bentham Science, 2018 (RESEARCH)
    • Top-10 2017 IQVIA Prime Sites in the World and Top 2017 IQVIA Malaysia Prime Sites for Clinical Investigation Centre (CIC) [7th position, in the global Top-10 2017 IQVIA Prime Sites, 3rd position, in the Top-5 2017 IQVIA APAC Prime Sites and 1st position, in the 2017 IQVIA Malaysia Prime Sites], IQVIA, 2018 (SERVICES)
    • 2018 Albert Nelson Marquis Lifetime Achievement Award, Marquis Who's Who, 2018 (OTHERS)
    • Biography Listed in Who'S Who in The World 2018, Marquis Who'S Who in The World, 2018, (International), Marquis Who'S Who in The World, 2018 (OTHERS)
    • Certificate of Excellent Service 2017, University of Malaya, 2017 (SERVICES)
    • 2017 Albert Nelson Marquis Lifetime Achievement Award , Marquis Who's Who, 2017 (OTHERS)
    • Excellence Service Award (APC) 2016, University of Malaya, 2016 (SPECIAL)
    • Next Generation Scientist Program 2016 in Basel, Switzerland - awarded to my ph.D student (Navin Kumar s/o Loganadan), Novartis Pharma AG, Basel Switzerland, 2016 (RESEARCH)
    • INSPIRE SITE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) for Clinical Investigation Centre (CIC)(International), Pfizer Inc, 2016 (OTHERS)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2016 (CERTIFICATE)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2015 (CERTIFICATE)
    • UM EXCELLENCE AWARD, NAIB CANSELOR, 2015 (CERTIFICATE)
    • INSPIRE SITE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) for Clinical Investigation Centre (CIC)(International), Pfizer Inc, 2015 (RESEARCH)
    • Best Poster Award - 8th Euro Global Diabetes Summit and Medicare Expo - November 03-05, 2015- Valencia, Spain, Omics International, 2015 (RESEARCH)
    • University of Malaya Excellence Award 2015 (Best Academic Administrator), University of Malaya, 2015 (SPECIAL)
    • Biography listed in Who's Who in the World 2016 (33rd Edition), Marquis Who's Who in the World, 2015 (SPECIAL)
    • Top 100 Health Professionals 2015, International Biographical Centre, Cambridge, England, 2015 (OTHERS)
    • The only Prime Site in the Asia Pacific region that has all new studies recruit the first patient within 100 days in 2014 for Clinical Investigation Centre (CIC), Quintiles, 2015 (RESEARCH)
    • Excellence Service Certificate (SPC) 2015, University of Malaya, 2015 (SPECIAL)
    • Excellence Service Certificate (SPC) 2014, University of Malaya, 2014 (SPECIAL)
    • INSPIRE SITE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) for Clinical Investigation Centre (CIC)(International), Pfizer Inc, 2014 (RESEARCH)
    • Biography listed in Who's Who in the World 2015 (32nd Edition), Marquis Who's Who in the World, 2014 (OTHERS)
    • CERTIFICATE OF EXCELLENT SERVICE, University of Malaya, 2014 (CERTIFICATE)
    • EXCELLENCE SERVICE AWARD, University of Malaya, 2013 (CERTIFICATE)
    • Best Prime Site in the world in Study Subject Recruitment Number at the half-year mark of 2013; for Clinical Investigation Centre (CIC), Quintiles (International), 2013 (RESEARCH)
    • Asian Manufacturing Awards; Pharmaceutical Industry (Best Pharma Clinical Trials Service Provider) for Clinical Investigation Centre (CIC)(International), Contineo Media Pte Ltd, 2013 (SPECIAL)
    • INSPIRE SITE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) for Clinical Investigation Centre (CIC)(International), Pfizer Inc, 2013 (RESEARCH)
    • Excellence Service Award (APC) 2013, University of Malaya, 2013 (SPECIAL)
    • Best oral presenter (Ph.D category), The National University of Malaysia, 2011 (RESEARCH)
    • Biolnno Award 2010, MOSTI (International), 2010 (RESEARCH)
    • Biolnno Awards 2009, MOSTI (International), 2009 (RESEARCH)
    • Invention, Innovation and Technology Exhibition (ITEX) 2008, Malaysian Invention and Design Society (MINDS) (International), 2008 (RESEARCH)
    • Malaysian Technology Expo (MTE) 2007, Malaysian Association of Research Scientists (MARS), 2007 (RESEARCH)
    CONSULTANCY PROJECT
    (Project title),(Organisation),(Duration),(Role),(Level)
    • Editor for MIMS Gateway Website, MIMS Medica Sdn Bhd, 01/01/2012 to 01/01/2015 (National)
    PAPER PRESENTED
    (Title),(Event),(Date Presented),(Organiser),(Level)
    PLEANARY SPEAKER
  • Pharmaceutical Care in COVID 19: What a Clinical Pharmacist Can Do to Alleviate the DIsease Burden ?, 7th International Conference on Pharmacy and Advanced Pharmaceutical Sciences (ICPAPS 2021) in collaboration with the 12th Annual Conference of the Indonesian Society for Cancer Chemoprevention (ISCC 2021), 03/11/2021 to 03/11/2021, Universitas Gadjah Mada (UGM) (International)
  • INVITED SPEAKER
  • Masking obstacles of scientist mothers: Silence epidemic within a pandemic, USM Pharmacy Webinar, 11/07/2020 to 11/07/2020, Science University of Malaysia (National)
  • Bridging the Gap between Laboratories and Market, Biosimilar Carnival 2018, 29/10/2018 to 30/10/2018, Innobioventures and MESTECC (International)
  • Landscape and Perspective of Regenerative Medicine Clinical Trials, Innovation Forum: Entrepreneurship in Health Care, 21/09/2018 to 22/09/2018, Innovation Forum Global and University Malaya (International)
  • Clinical Investigation Centre (CIC), Science Cafe -FOM Shared Research Facility, 14/08/2018 to 14/08/2018, Faculty of Medicine (University)
  • Good Clinical Practice (GCP), Pre-Clinical and Phase I Clinical Trials in the Cell-Based Therapy and Drug Development, 26/02/2018 to 26/02/2018, NOCERAL (National)
  • EVENT ORGANISER
  • Introduction to CIC , CIC Clinical Trial Attachment Program, 23/01/2019 to 24/01/2019, CIC (National)
  • GCP Workshop, GCP Workshop December 2018, 04/12/2018 to 06/12/2018, Clinical Investigation Centre (CIC) (National)
  • GCP Workshop, GCP Workshop October 2018, 23/10/2018 to 25/10/2018, Clinical Investigation Centre (CIC) (National)
  • GCP Workshop, GCP Workshop July 2018, 03/07/2018 to 05/07/2018, Clinical Investigation Centre (CIC) (National)
  • GCP workshop, GCP workshop March 2018, 20/03/2018 to 22/03/2018, Clinical Investigation Centre (CIC) (National)
  • Harmonisation and Synchronisation of Undergraduate Pharmacy Curriculum, Pharmacy Education Symposium 2015, 16/10/2015 to 17/10/2015, Department of Pharmacy, Faculty of Medicine, University of Malaya (National)
  • Pharmacy: Leading & Managing Change, 11th MPS-PSC 2012, 31/10/2012 to 02/11/2012, Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur,MPS Malaysia, Pharmaceutical Services Division, MOH, Malaysia. (International)
  • ORAL PRESENTER
  • Optimizing glycemic control in type 2 diabetes mellitus patients during severe/acute hyperglycemic phase: From predictors to a new approach, Diabetes Asia 2011, 06/10/2011 to 09/10/2011 (International)
  • Optimizing the glycemic control in type 2 diabetes patients during severe/acute hyperglycemic phase: From predictors to a new approach, UKM Research Day, 20/07/2011 to 20/07/2011, Universiti Kebangsaan Malaysia (University)
  • POSTER PRESENTER
  • Pharmacometabolomics of Meformin demonstrated insulin sensitivity related pathways at peak plasma concentration on healthy volunteers Preliminary results, 18th World Congress Insulin Resistance Diabetes & Cardiovascular Disease (WCIRDC), 03/12/2020 to 06/12/2020, The Metabolic Institute of America (TMIOA) (International)
  • Association of YKL-40 Encoding Gene CHI3L1 rs946263 with Insulin Resistance and Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus Patients, 18th World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) , 03/12/2020 to 06/12/2020, The Metabolic Institute of America (TMIOA) (International)
  • THE IMPACT OF ACADEMIC DETAILING ON ENHANCING STATIN THERAPY PRESCRIBING IN MALAYSIAN PRIMARY CARE SETTINGS: QUASI-EXPERIMENTAL DESIGN, ISPOR 23rd Annual International Meeting, 21/05/2018 to 21/05/2018, ISPOR (International)
  • Navin Kumar Loganadan, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Zanariah Hussein. Association Between Pancreatic Beta Cell Function and Glycemic Control of Type 2 Diabetes Patients on Maximal Sulphonylurea Therapy. Journal of the ASEAN Federation of Endocrine Societies 2015. 30 (2): 101. , ASEAN Federation of Endocrine Societies (AFES) Congress, 10/12/2015 to 13/12/2015, ASEAN Federation of Endocrine Societies (AFES) (International)
  • Natural Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis induces apoptosis through activation of intrinsic, extrinsic and NF- B signaling pathways on human prostate cancer PC3 cells in vitro, 12th MPS Pharmacy Scientific Conference 2015 (MPS-PSC 2015) , 13/11/2015 to 15/11/2015, Malaysian Pharmaceutical Society (International)
  • The association of WFS1 gene polymorphisms with the DPP-4 inhibitors treatment response in type 2 diabetes, 8th Euro Global Diabetes Summit and Medicare Expo - November 03-05, 2015- Valencia, Spain, 03/11/2015 to 05/11/2015 (International)
  • Pathway Mechanism of Potential Genomic Markers of Dipeptidyl Peptidase-4 Inhibitor Treatment Response in Type 2 Diabetes, Golden Helix Symposium 2015, 12/03/2015 to 13/03/2015 (International)
  • Impact of Single Nucleotide Polymorphisms(SNPs) of Type 2 Diabetes (T2D) Genes on Patients Response to Sulphonylurea Therapy, Golden Helix Symposium 2015, 12/03/2015 to 13/03/2015 (International)
  • Association of Genetic Polymorphisms of Dipeptidyl Peptidase-4 with Metabolic Syndrome Parameters in Malaysian Subjects, Golden Helix Symposium 2015, 12/03/2015 to 13/03/2015 (International)
  • Potential biomarkers of Insulin Resistance and Atherosclerosis among T2DM patients with Coronary Artery Disease, 12th International Congress on Obesity, 17/03/2014 to 20/03/2014 (International)
  • Demographic and Clinical Predictors for Insulin Resistance in Type 2 Diabetes Mellitus Patients During Severe/Acute Hyperglycemia Phase, 1st Asia Pacific Clinical Epidemiology and Evidence-Based Medicine Conference, 06/07/2012 to 08/07/2012 (International)
  • A survey about self monitoring of blood glucose amongst type 2 diabetes inpatients, 14th Congress of Asean Federation of Endocrine Societies (AFES), 30/11/2007 to 02/12/2007, Asean Federation of Endocrine Societies (International)
  • Pharmacy Programme and Clinical Pharmacy Teaching in the University of Malaya, International Conference on Clinical Pharmacy Education; Tokyo, Japan, 02/06/2006 to 03/06/2006 (International)
  • PRESENTER
  • Association between abcc8 rs757110 (ser1369ala) gene polymorphism and sulphonylurea response in Malaysian type 2 diabetes patients, 77th FIP World Congress of Pharmacy and Pharmaceutical Sciences, 10/09/2017 to 14/09/2017, International Pharmaceutical Federation (FIP) (International)
  • Abu Bakar, Mohamad Hafizi; Zaman Huri, Hasniza; Hairunisa, Nany. Alterations of cultured myotubes and fasting plasma metabolite profile related to mitochondrial dysfunction in Type 2 diabetes subjects, OCC World Congress 2017 and Annual SFRR-E Conference , 21/06/2017 to 23/06/2017, OCC World Congress 2017 and Annual SFRR-E Conference  (International)
  • Genetic Polymorphisms in Uncontrolled Type 2 Diabetes Mellitus with Overweight and Obesity Patients, Monash Science Symposium 2016, 21/11/2016 to 23/11/2016, Monash University Malaysia (International)
  • Glycemic Control Among Simvastatin User In Diabetic Patients With Oral Antidiabetic, Monash Science Symposium 2016, 21/11/2016 to 23/11/2016, Monash University Malaysia (International)
  • Demographic and clinical predictors for type 2 diabetes patients during severe/acute hyperglycemic phase, 1st Asia Pacific Clinical Epidemiology and Evidence Based Medicine, 06/07/2012 to 08/07/2012 (International)
  • KEYNOTE SPEAKER
  • Heart failure with type 2 diabetes: Prescribing patterns of antihyperglycemic agents and the association between glycemic control with ejection fraction, Webinar on Clinical Pharmacy and Clinical Research, 16/04/2021 to 16/04/2021, Allied Academies (International)